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The Runt domain transcription factor RUNX3 is a prominent tumour suppressor in the 
gastrointestinal tract where it is required for proper proliferation and differentiation of 
gastric epithelial cells. These functions are partly elicited by mediating the tumour 
suppressive TGF-β/SMAD signaling and antagonising the oncogenic Wnt pathway. 
Consistent with these, immoralised Runx3-/- gastric epithelial cells (GIF lines) are 
refractory to TGF-β1-induced apoptosis and are tumorigenic in nude mice, but not 
their Runx3+/+ equivalents. In this study, we observed the spontaneous emergence of a 
tumorigenic and stem-cell like subpopulation, P2 through Epithelial-Mesenchymal 
Transition (EMT) in Runx3-/- GIF-14 cells. Paradoxically, EMT was driven by 
aberrantly activated TGF-β signaling, suggesting that the loss of Runx3 render cells 
sensitised to the EMT-promoting functions of TGF-β. Interestingly, the P2 
subpopulation expressed markedly higher levels of Lgr5, a canonical Wnt target gene 
that is exclusively expressed in the pyloric gastric stem cells. Moreover, TGF-β1-
induced EMT reactivates Lgr5 which acts synergistically with Wnt3a to cause 
amplified activation of Lgr5. This observation was largely absent in Runx3+/+ GIF-13 
cells. Finally, the re-introduction of RUNX3 in GIF-14 cells strongly abrogated 
Wnt3a-induced Lgr5, reduced the P2 subpopulation and TGF-β1-activated EMT- and 
stemness-related genes such as Hmga2, Snai1 and Lgr5, confirming the negative roles 
of RUNX3 on EMT and stemness. Taken together, our data revealed that Runx3 
maintains gastric epithelial cell integrity and its absence causes sensitisation to Wnt 
and EMT-activating properties of TGF-β, resulting in increased cellular plasticity and 





























1.1 The RUNX family of transcription factors 
The RUNX family of transcription factors plays pivotal roles in mammalian 
developmental processes (Ito, 1999).  The RUNX family is evolutionarily conserved 
from the nematode worm Caenorhabditis elegans to fruitfly Drosophila melanogaster 
and in mammals, indicating that RUNX proteins have pivotal functions even in the 
most primitive metazoan and unicellular holozoan (Sullivan et al., 2008; Sebe-Pedros 
et al., 2011). RUNX was initially discovered by independent groups to be a nuclear 
protein that binds to the enhancer elements of polyomavirus and Moloney murine 
leukemia viruses (Kamachi et al., 1990; Speck et al., 1990). It was found that the 
RUNX genes encoded the DNA-binding α-subunits of the heterodimeric transcription 
factor, known as polyomavirus enhancer-binding protein 2 or core-binding factor 
(PEBP2/CBF) (Ito, 2004). The founding member of the RUNX gene family is Runt, a 
Drosophila pair-rule gene that controls the segmentation in embryos and is required 
for neurogenesis and sex determination (Kania et al., 1990; Duffy et al., 1991; Duffy 
and Gergen, 1991; Ingham and Gergen, 1998). To date, three mammalian runt-related 
genes RUNX1, RUNX2 and RUNX3 have been characterised which play distinct 
biological roles during development and diseases. 
The RUNX family members share a high degree of sequence and structural 
homology where they contain a highly conserved 128-amino-acid Runt domain and a 
5- amino-acid VWRPY domain (Ito, 1999). The high level of sequence conservation 
reflects a crucial importance of these domains to the function of RUNX proteins. The 
Runt domain is critical for RUNX proteins to function as transcription factors as it 
confers sequence-specific DNA binding and dimerisation with their non DNA-
binding partner, core-binding factor β (CBFβ) (Kamachi et al., 1990). Although the 
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Runt domain can bind DNA independently, its binding affinity and hence 
transcriptional activity is greatly enhanced when dimerised with CBFβ (Ogawa et 
al.,1993; Ogawa et al., 1993). The VWRPY motif located at the carboxyl-terminal 
modulates the transcriptional activity of RUNX proteins by recruiting co-repressors 
such as the transducin-like enhancer (TLE)/Groucho (Levanon et al., 1994; Aronson 
et al., 1997).  
Studies in both Drosophila and mammalian systems suggest that RUNX 
proteins act as context-dependent transcription regulators, which either activate or 
repress gene expression by cooperating with different transcription factors or 
cofactors in specific cell or tissue types (Wheelers et al., 2000).  A classic example of 
synergistic interaction between RUNX proteins and other transcription factors is the 
cooperative DNA binding and transcriptional activation of T cell receptor and 
Moloney murine leukemia virus enhancer elements by RUNX1 and Est-1 (Wotton et 
al., 1994; Sun et al., 1995; Kim et al., 1999). RUNX1 also cooperates with Myb, 
PU.1 and C/EBPα transcription factors to transactivate various promoters and 
enhancers of the hematopoietic genes (Hernandez-Munain and Krangel, 1994; Zaiman 
and Lenz, 1996; Zhang et al., 1996; Britos-Bray and Friedman, 1997; Petrovick et al., 
1998). In other cases, RUNX proteins recruit co-repressors such as TLE/Groucho to 
transcriptionally repress hematopoietic and osteoblastic genes (Imai et al., 1998; 
Javed et al., 2000). Besides associating with co-repressors, RUNX1 interacts with 
p300/CREB-binding proteins (CBP) to recruit histone acetyltransferase, p300/CBP-
associating factor (P/CAF), resulting in epigenetic derepression of myeloperoxidase 
(MPO) during myeloid differentiation (Kitabayashi and Yokoyama et al., 1998). 
Being intricately involved in cell fate determination during development as prominent 
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regulators of gene expression, it is not surprising that the dysregulation of the Runt 
domain-containing genes are often associated with oncogenesis. 
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1.2 Important roles of RUNX genes in development and human cancers  
1.2.1 RUNX1 in hematopoiesis and human leukemia 
Amongst the most studied RUNX genes is Runx1, often regarded as the master 
regulator of adult hematopoiesis in vertebrates. Homozygous deletion of Runx1 in 
mice resulted in complete lack of fetal liver hematopoiesis suggesting that Runx1 is 
absolutely required for definitive hematopoiesis (Okuda et al., 1996; Wang et al., 
1996). In this context, Runx1 is indispensible for the emergence of the first 
hematopoietic stem cells (HSCs) from hematogenic endothelial clusters in the 
embryonic aorta-gonad-mesonephros (AGM) region (North et al., 1999; Yokomizo et 
al., 2001). Conditional targeting of Runx1 in adult mice led to an initial expansion of 
short term HSCs with limited self-renewal capacity, which was followed by stem cell 
exhaustion at a later stage (Ichikawa et al., 2004; Motoda et al., 2008; Jacob et al., 
2010). This is thought to be the result of compromised HSC-niche interactions (Jacob 
et al., 2010). HSCs exhibiting long term self-renewal activity would exit quiescence 
due to disrupted HSC-niche associations to become short term HSCs, eventually 
leading to stem cell exhaustion (Wang et al., 2010). These evidences indicate a role of 
Runx1 in maintaining HSCs in quiescence through a niche-related mechanism. These 
data also suggest that Runx1 deficiency triggers a pre-leukemic state by increasing the 
number of short term HSCs as a cell pool for further oncogenic alterations, leading to 
leukemia development (Growney et al., 2005; Putz et al., 2006). In further support of 
these observations, Runx1-deficient mice developed myelodysplastic syndrome and 
thymic lymphoma, indicating a precancerous condition (Putz et al., 2006). Apart from 
its function in adult HSCs, Runx1 is also essential for terminal differentiation of 
hematopoietic progenitors of the megakaryocytic and lymphocytic lineages (Ichikawa 
et al., 2004). During the development of T lymphocytes, Runx1 is required for active 
6 
 
repression of CD4 in CD4-CD8- double negative immature thymocytes through direct 
binding to two Runx-binding motifs in the CD4 silencer (Taniuchi et al., 2002). It is 
apparent that Runx1 is involved in multiple levels of adult hematopoiesis from the 
maintenance of quiescent HSCs to defining proper differentiation programs towards 
the full range of hematopoietic lineages.  
Given its pivotal roles in mammalian hematopoiesis, RUNX1 is one of the 
most frequently disrupted genes in human leukemias (Look et al., 1997). Loss of 
RUNX1’s function due to chromosomal translocations and point mutations is featured 
strongly in various types of leukemias such as acute myelogenous leukemia, 
myelodysplastic syndrome, chronic myelogenous leukemia and childhood acute 
lymphoblastic leukemia (Nucifora et al., 1993; Mitani et al., 1994; Golub et al., 1995). 
Inactivation of RUNX1 predisposes patients to the development of leukemias upon 
further genetic mutations. Therefore, RUNX1 is a key regulator of embryonic and 
adult hematopoiesis where its disruption is strongly linked to leukemogenesis.  
 
1.2.2    RUNX2 regulates bone development  
RUNX2 is a major transcription factor required for bone formation in 
mammals. Genetic ablation of Runx2 resulted in impaired osteoblasts maturation and 
osteogenesis, leading to complete lack of bone formation. Therefore, Runx2-/- mice die 
soon after birth from severe respiratory defects possibly caused by the absence of a rib 
cage (Komori et al., 1997; Otto et al., 1997). Consistent with this phenotype, Runx2 
regulates bone-specific genes such as osteocalcin and alkaline phosphatase during 
osteoblast differentiation from mesenchymal precursor cells (Ducy et al., 1999). 
Runx2 heterozygous mice displayed skeletal abnormalities resembling that of the 
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human congenital skeletal disorder, cleidocranial dysplasia. Importantly, loss-of-
function mutations in RUNX2 were found in patients suffering from this disease (Otto 
et al., 2002; Tessa et al., 2003; Xuan et al., 2008). In the context of cancer, RUNX2 
was reported to promote breast and prostate tumour growth, and their metastasis to the 
bone (Javed et al., 2005; Pratap et al., 2008; Das et al., 2009; Akech et al., 2010; Lim 
et al., 2010). Moreover, Runx2 cooperated strongly with c-myc to induce T-cell 
lymphoma in transgenic mouse models (Stewart et al., 1997).  
 
1.2.3    RUNX3 regulates neuron and lymphocyte development 
Compared to its other mammalian members, Runx3 is expressed in a relatively 
diverse cell types including the dorsal root ganglion neurons, hematopoietic cells and 
various epithelial organs including the lung, liver and the gastrointestinal tract. As a 
result, Runx3-/- mice displayed abnormalities in these tissues such as motor 
discoordination, disrupted cytotoxic T lymphocyte function and hyperplasia in the 
gastrointestinal epithelium (Inoue et al., 2002; Levanon et al., 2002; Li et al., 2002; 
Taniuchi et al., 2002; Woolf et al., 2003; Ito et al., 2008). Runx3 controls the axonal 
projection of proprioceptive dorsal root ganglion neurons, and thus the deletion of 
Runx3 led to the loss of these cells and ataxia (Inoue et al., 2002; Levanon et al., 
2002). Distinct from the active repression of CD4 in CD4-CD8- double negative 
immature thymocytes by Runx1, Runx3 is necessary for epigenetic silencing of CD4 
in CD4-CD8+ mature cytotoxic thymocytes (Taniuchi et al., 2002; Woolf et al., 2003). 
Runx3-null CD4-CD8+ T cells, but not helper CD4+CD8- T cells failed to proliferate 
and displayed defective cytotoxic activity, suggesting that Runx3 has critical 
functions in lineage specification and homeostasis of CD4-CD8+ lineage T 
lymphocytes (Taniuchi et al., 2002).  
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1.2.4 RUNX3 is a gastrointestinal tumour suppressor  
A function of Runx3 in the gastrointestinal epithelium was first implicated by 
the pronounced hyperplastic gastric epithelium of the Runx3-knockout mice. Further 
analysis revealed that the glandular stomach displayed excessive cell proliferation and 
inhibition of apoptosis in these epithelial cells (Li et al., 2002; Ito et al., 2008). The 
dysregulated proliferation and apoptosis experienced by gastric epithelial cells 
following the loss of Runx3 are consistent with its role as a tumour suppressor in this 
tissue type. However, the neonatal death of Runx3-deficient mice in C57BL/6 genetic 
background has hampered the detailed analysis of their phenotypes. To overcome this, 
a series of immortalised mouse gastric epithelial cell lines, termed GIF lines, were 
established from the entire stomach epithelia of Runx3+/+ and Runx3-/- E16.5 fetuses 
in a p53-/- background (Li et al., 2002). Concordant with the tumour suppressive 
properties of Runx3, Runx3-/-.p53-/- embryonic GIF cell lines but not their 
Runx3+/+.p53-/- equivalents formed tumours when transplanted in immuno-
compromised nude mice (Li et al., 2002).  
More recently, Runx3-/- mice in BALB/c genetic background that survived up 
to one year were generated. Analysis of these mice revealed that spasmolytic 
polypeptide-expressing metaplasia (SPEM), a precancerous metaplasia developed in 
the gastric mucosa due to altered differentiation of the gastric epithelial cells (Ito et al., 
2011). As Runx3 is prominently expressed in pepsinogen-positive chief cells and 
Muc5AC-positive surface mucous cells, it may be involved in the differentiation of 
these lineages. Indeed, Runx3-/- mice exhibited loss of chief cells and antralisation of 
the fundic stomach. This was likely consequent to a block in chief cell differentiation 
or trans-differentiation of chief cells into SPEM cells (Ito et al., 2011). Remarkably, 
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the induction of an intestinal phenotype with ectopic expression of the intestinal-
specific transcription factor Cdx2 was observed in the gastric mucosa of Runx3-/- adult 
mice (Ito et al., 2011). These observations suggest that Runx3-/- gastric epithelial cells 
possess a disrupted gastric epithelial identity and their differentiation in vivo is easily 
altered by extracellular morphogenetic cues. More importantly, Runx3-/- SPEM was 
readily transformed into adenocarcinomas in the stomach by exposure to the 
carcinogen, N-methyl-N-nitrosourea (MNU), indicating that loss of Runx3 induces a 
pre-neoplastic condition in the stomach (Ito et al., 2011).   
Consistent with the disrupted differentiation in adult BALB/c Runx3-/- mice, 
Runx3-/-.p53-/- embryonic GIF cell lines displayed impaired cell-cell adhesion, 
epithelial cell polarity and altered differentiation in vitro. When cultured between 
collagen sheets, Runx3+/+.p53-/- GIF lines readily formed simple columnar epithelia 
with glandular structures exhibiting intact cell-cell adhesion and apical-basal polarity 
(Fukamachi et al., 2004). In contrast, Runx3-/-.p53-/- GIF lines under similar culturing 
conditions displayed altered differentiation as reflected in the inability to form 
glandular structures (Fukamachi et al., 2004). These phenotypes were attributed in 
part to the significantly reduced expression of tight junction proteins critical for cell-
cell adhesion, such as Claudin-1 which was discovered to be a positive target of 
RUNX3 in gastric epithelial cells (Chang et al., 2010). These data suggests that 
Runx3 is crucial for the proper differentiation into glandular epithelial sheet with 
established cell-cell adhesion and polarity in collagen cultures. As Runx3-/-.p53-/- GIF 
cell lines formed tumours in nude mice, these tumours were analysed for their 
differentiation capacity. Akin to intestinalisation observed in adult BALB/c Runx3-/- 
mouse stomachs, analysis of the tumours derived from nude mice and in vitro culture 
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in three dimensional matrigel revealed that Runx3-/- GIF cell lines could trans-
differentiate into intestinal-type cells (Fukamachi et al., 2004). These observations 
indicate that Runx3-/- gastric epithelial cells display cellular plasticity as they are 
prone to the influences of extracellular stimuli. 
The tumour suppressive activities of Runx3 revealed in the analysis of Runx3-/- 
mice are firmly supported by human clinical data. In human, loss of RUNX3 
expression is strongly correlated to the genesis and progression of gastric cancer. 
Silencing of RUNX3 was observed in more than 80% of primary gastric tumours and 
gastric cancer cell lines due to hemizygous deletions, promoter hypermethylation and 
protein mislocalisation in the cytoplasm (Li et al., 2002; Ito et al., 2005). Moreover, 
RUNX3 inactivation was also prevalent in human colorectal carcinomas in which 
RUNX3 was silenced in 40% of primary colorectal tumours and 60% of colorectal 
cancer cell lines (Ito et al., 2008). In addition, downregulation of RUNX3 was 
frequently observed in intestinal metaplasia (IM) which is often regarded as a 
precancerous state in gastric cancer (Li et al., 2002). Similarly, inactivation of 
RUNX3 induced intestinal adenomas in both human and mice, which provided 
favourable conditions for the progression of these adenomas to malignant 
adenocarcinomas (Ito et al., 2008). Together, these mouse and human data strongly 
argue that RUNX3 functions as a tumour suppressor in the gastrointestinal tract, 
where its disruption appears to be a key event in early gastrointestinal carcinogenesis.  
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1.3 The involvement of RUNXs in major signaling pathways 
1.3.1 RUNXs are integral components of the TGF-β/SMAD signaling cascade 
Transforming growth factor-β (TGF-β) is a family of multifunctional 
cytokines that regulate growth, differentiation, apoptosis, matrix accumulation and 
motility of many cell types (Blobe et al., 2000). TGF-β acts as a potent inhibitor of 
cell growth in hematopoietic cells, endothelial cells and epithelial cells, whereas it 
stimulates the growth of mesenchymal cells (Derynck et al., 2001). Members of the 
TGF-β superfamily consist mainly of TGF-βs, activins and bone morphogenetic 
proteins (BMPs). The binding of these TGF-β ligands results in the formation of type 
I and type II receptor heterodimeric complex which leads to the activation of 
downstream effectors of the SMAD family. The receptor-activated SMADs (R-
SMADs) become phosphorylated and associate with SMAD4 (Co-SMAD) and 
translocate to the nucleus to regulate transcription of target genes together with other 
transcription factors (Feng and Derynck, 2005; Massague et al., 2005). SMAD2 and 
SMAD3 serve as R-SMADs transducing the TGF-β/activin-like signals while 
SMADs 1, 5 and 8 act as R-SMADs mediating BMP-like signals (Miyazono et al., 
2004). The roles of TGF-β family members in carcinogenesis are complex as they 
demonstrate both tumor suppressive and oncogenic potentials. In the current paradigm, 
the tumour suppressive function of TGF-β dominate in normal tissues and in early 
stages of cancer, but in advanced cancers, changes in TGF-β expression and cellular 
responses tip the balance in favor of its oncogenic activities (Derynck et al., 2001). 
These are supported by the implication that activated TGF-β signaling promotes 
cancer progression and metastasis via epithelial-mesenchymal transition (EMT), 
angiogenesis and immuno-suppression (Wakefield and Roberts, 2002). 
12 
 
Interestingly, some of the biological functions of the TGF-β cytokines are 
similar to those of RUNX proteins. Indeed, all three RUNXs have been shown to 
physically interact with R-SMADs (Hanai et al., 1999). For instance, RUNX3 
interacted with Smad2 and Smad3 to cooperatively activate germline immunoglobulin 
constant α (IgCα) promoter to direct class switching to IgA in B lymphocytes (Hanai 
et al., 1999; Pardali et al., 2000). During BMP-induced osteoblastic differentiation, 
the physical interaction between Runx2 and BMP-specific Smad1 and Smad5 
synergistically activated osteoblast-specific gene expression in pluripotent 
mesenchymal precursor cells (Lee et al., 2000). Importantly, impaired RUNX2-
SMAD interaction due to mutations in RUNX2 may contribute to the pathogenesis of 
cleidocranial dysplasia (Zhang et al., 2000). In contrast to the synergy between 
RUNXs and SMADs on their target genes, the association of Runx2 and TGF-β-
specific Smad3 led to transcriptional repression of osteoclacin, and thus inhibited 
osteoblast differentiation (Alliston et al., 2001). Based on these evidences, RUNX 
proteins act as nuclear effectors of the TGF-β signaling pathway through the 
formation of complexes with specific R-SMADs to control transcription in a context 
dependent manner. 
TGF-β/SMAD signaling cascade is one of the central pathways that controls 
the growth and differentiation of gut epithelial cells (Mishra et al., 2005). The role of 
TGF-β signaling as a tumour suppressor pathway in the gastrointestinal tract is best 
illustrated by the prevalent inactivating mutations in several components of the TGF-
β signaling cascade such as the type II TGF-β receptor and SMAD4 in gastrointestinal 
cancers (Park et al., 1994; Markowitz et al., 1995; Lu et al., 1996; Howe et al., 1998; 
Xu et al., 2000). In gastric epithelial cells, RUNX3 mediates the tumour suppressive 
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effect of TGF-β by cooperating with R-SMADs to activate the transcription of the 
negative regulator of cell cycle, p21WAF/Cip1 and proapoptotic gene, BIM (Chi et al., 
2005; Yano et al., 2006; Ito, 2008). Concordant with this, Runx3-/-.p53-/- GIF cells 
were resistant to TGF-β1-induced growth arrest and apoptosis (Li et al., 2002). 
Therefore, it appears that an important part of the tumour suppressor function of 
RUNX3 is achieved through the modulation of the TGF-β pathway. 
 
1.3.2 RUNX3 attenuates the oncogenic Wnt signaling pathway 
In mammals, the canonical Wnt pathway is critical in cell fate determination 
in embryogenesis and orchestrates self-renewal in various tissues (Clevers, 2006). 
Wnt signaling promotes the stabilisation of cytoplasmic β-catenin through functional 
deactivation of glycogen synthase kinase-β (GSK3β) which phosphorylates β-catenin. 
As a result, unphosphorylated β-catenin is translocated to the nucleus to stimulate the 
transcription of Wnt target genes by interacting with the T-cell factor (TCF) or 
lymphoid enhancer-binding factor (LEF) transcription factors (Bienz and Clevers, 
2000). The critical role of Wnt/TCF4/β-catenin signaling in intestinal homeostasis is 
best demonstrated by the phenotype of homozygous Tcf-4 knockout mice. Strikingly, 
the proliferative stem cell compartment was entirely absent in the small intestines of 
Tcf-4-/- neonatal mice, suggesting that Wnt/TCF4/β-catenin pathway is necessary for 
the maintenance of crypt stem/progenitor cells in intestinal epithelium (Korinek et al, 
1998). Recently, a new pool of intestinal stem cells, the crypt base columnar (CBC) 
cells marked by the Wnt target gene, leucine-rich repeat-containing G-protein 
coupled receptor 5 (Lgr5) has been characterised (Barker et al., 2007). Lineage 
tracing experiments using Lgr5-EGFP-IRES-creERT2.Rosa26-lacZ compound mice 
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revealed that Lgr5-positive cells gave rise to all lineages of the intestinal epithelium 
and maintained the epithelia self-renewal over a long period of time (Barker et al., 
2007). Subsequently, Lgr5 was reported to demarcate an analogous stem cell 
compartment in the pyloric stomach (Barker et al., 2010). This was supported by the 
ability of single Lgr5-positive cells to form intestinal/gastric three-dimensional 
organoid structures, resembling those of normal gastrointestinal epithelium (Sato et 
al., 2009; Barker et al., 2010).  
As a major growth factor pathway, the dysregulation of Wnt signaling is 
strongly implicated in gastrointestinal cancers (Clevers, 2006). Constitutive activation 
of the Wnt pathway, either through the inactivation of the adenomatous polyposis coli 
(APC) complex or gain of oncogenic mutations in β-catenin results in the aberrant 
stabilisation and nuclear accumulation of β-catenin (Kinzler and Vogelstein, 1996; 
Bienz and Clevers, 2000). In mouse, this phenomenon is readily reproduced and 
studied in the Apcmin/+ transgenic mouse model, which carries a heterozygous 
mutation at codon 850 of the Apc tumour suppressor gene (Moser et al., 1992). The 
Apcmin/+ mice developed intestinal adenomas spontaneously, which bears close 
resemblance to the phenotype of aged BALB/c Runx3+/- mice (Moser et al., 1992, Ito 
et al., 2008). RUNX3 functions as an attenuator of the Wnt pathway and this was 
reflected in the increased intestinal tumour incidence and mass in Runx3+/-.Apcmin/+ 
compound mutant mice (Ito et al., 2008). Consistent with this, increased Wnt 
signaling activity was observed in BALB/c Runx3-/- gastrointestinal epithelium as 
reflected in the upregulation of Wnt target genes such as c-Myc, cyclinD1, EphB2 and 
CD44 (He et al., 1998; Tetsu and McCormick, 1999; Batlle et al., 2002; van de 
Wetering et al., 2002). Due to aberrant activated Wnt signaling in the intestinal 
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epithelium, paneth cells were mislocated from their normal positions at the base of the 
crypt, indicative of profound disruptions to intestinal differentiation (Ito et al., 2008). 
The molecular mechanism underlies the antagonist effects of RUNX3 on Wnt 
signaling is through a direct interaction with the TCF4/β-catenin complex, thus 
revealing a new aspect to its role as a gastrointestinal tumour suppressor.  
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1.4 Understanding the interplay between RUNX3, TGF-β and Wnt 
It is known that the disruption of key regulators of cell proliferation, apoptosis 
and differentiation would lead to the development of gastrointestinal cancers. The 
transcription factor RUNX3 appears to be one such important player which intersects 
multiple key signaling pathways to regulate gene expression. Earlier studies have 
shown that the inactivation of Runx3 in mice would result in defective cell 
proliferation, apoptosis and differentiation in the gastrointestinal epithelium, due to 
the dysregulation of TGF-β and Wnt signaling pathways, rendering them 
precancerous conditions (Li et al., 2002; Ito et al., 2008; Ito et al., 2010). Despite 
these findings, the precise changes in the cell biology of gastric epithelial cells due the 
loss of RUNX3 and how they contribute to tumorigenicity are not fully understood. 
To investigate this, the Runx3+/+.p53-/- and Runx3-/-.p53-/- gastric epithelial cell lines, 
which have been partially characterised in earlier studies can be used (Li et al., 2002; 
Fukamachi et al., 2004). An important feature of the Runx3-/- GIF lines is that they are 
weakly tumorigenic when transplanted into nude mice, unlike their Runx3+/+ 
counterparts which do not produce tumours. However, individual GIF cell lines were 
each established from a whole fetal stomach epithelia that consisted a mixture of cell 
types and had not gone through clonal selection. Therefore, they are heterogeneous in 
nature. This heterogeneity is compounded by additional genetic and epigenetic 
changes gained during extended in vitro culture in the absence of p53. As such, 
distinct subpopulations exist within individual Runx3-/- GIF cell lines and the observed 
tumorigenicity may be restricted to specific subpopulations. This study aims to 
identify the tumour-initiating cells within these Runx3-/- GIF cells. This will be 
followed by a thorough interrogation of the identified tumorigenic cell population to 
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generate novel insights into the molecular basis of their tumorigenicity and its 
relationship with Runx3. 
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1.5 Experimental aims 
1. To identify the tumorigenic subpopulation within the Runx3-/-.p53-/- GIF-14 
gastric epithelial cells. 
 
2. To investigate the cause of the appearance of this subpopulation and the 
involvement of TGF-β and Wnt signaling pathways. 
 
3. To demonstrate the negative role of Runx3 in the emergence of the 

























2.1 Cell culture and growth factor treatments 
Murine gastric epithelial cell lines GIF-5, GIF-9, GIF-13, and GIF-14 were 
previously established from E16.5 Runx3+/+.p53-/- and Runx3-/-.p53-/- embryonic 
stomachs by Fukamachi (Fukamachi et al., 2004). They were maintained in 
Dulbecco’s Modified Eagle Medium (DMEM) (Invitrogen, CA, USA) supplemented 
with 4500mg/L glucose, 10% fetal bovine serum (FBS), 100 U/ml penicillin and 
100µg/ml streptomycin antibiotics (Hyclone, UT, USA). The cells were sub-cultured 
in 10-cm or 6-cm tissue culture dishes at 1:10 (Nunc A/S, Roskilde, Denmark), and 
maintained at 37oC in a humidified atmosphere containing 5% CO2. To activate TGF-
β pathway, cells were treated with 2.5ng/ml of human recombinant TGF-β1 (R & D 
systems, MN, USA) for the indicated periods prior to Hoechst 33342 staining, 
antibody staining and/or quantitative RT-PCR. TGF-β signaling was inhibited using 
10µM of small molecule TGF-β inhibitor, SB431542 (Sigma-Aldrich, MO, USA). To 
activate Wnt pathway, cells were treated with control- or Wnt3a-conditioned medium 
(Cm) for 15h prior to analysis. To study the contribution of various growth factors, 
cells were treated with 10ng/ml of murine recombinant epidermal growth factor 
(EGF), 10ng/ml of human recombinant EGF, 10ng/ml of human recombinant basic 
fibroblast growth factor (bFGF) and 10ng/ml of human recombinant FGF10 
purchased from PeproTech (NJ, USA) and 10ng/ml of human recombinant hepatocyte 
growth factor (HGF) purchased from Merck Biosciences-Calbiochem (NH, UK) prior 
measurement of transcriptional changes by quantitative RT-PCR. 
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2.2 Production of Wnt3a-conditioned medium  
Wnt3a- and control-conditioned media (Cm) were prepared following protocol 
described in Willert et al., 2003. Mouse L-cells producing secreted Wnt3a ligand and 
the parent L-cells were obtained from American Type Culture Collection (ATCC). 
They were cultured in DMEM supplemented with 4500mg/L glucose, 10% FBS, 100 
U/ml penicillin and 100µg/ml streptomycin antibiotics (Hyclone, UT, USA). Cells 
were passaged 1:10 in 15-cm tissue culture dishes and grown to confluency for 4 days. 
The first harvest of conditioned media was collected, and cells were washed with 
phosphate buffered saline (PBS) prior to addition of 15ml of fresh culture media. The 
second harvest of conditioned media was collected three days later, and mixed with 
media from the first harvest, prior to filter-sterilisation with a 0.45µm filter. 
Conditioned media was kept in -80°C for long term storage. 
 
2.3 Hoechst 33342 and surface antigen staining  
Cells were stained with Hoechst 33342 (Sigma-Aldrich, MO, USA) according 
to Goodell et al., 1996. Briefly, GIF cell lines were trypsinised and resuspended in 
DMEM supplemented with 4500mg/L glucose, 2% FBS, 10mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES; Invitrogen, CA, USA) and 10µg/ml Hoechst 
33342 in the presence or absence of 0.2mM verapamil (Sigma-Aldrich, MO, USA) at 
106 cells/ml. Cells were incubated at 37oC for 90min with regular mixing. Cells were 
then resuspended in pre-chilled Hanks’ balanced saline solution (HBSS; Invitrogen, 
CA, USA) containing 2% FBS and 10mM HEPES and subjected to flow cytometry 
analysis. For experiments involving co-staining of surface antigens, cells were stained 
by Hoechst 33342 prior to immunostaining with fluorochrome-conjugated antibodies 
against various surface antigens, primarily EpCAM and CD133. Cells were incubated 
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with anti-EpCAM-phycoerythrin-cyanine (PE-Cy7) (Biolegend, CA, USA; catalogue 
number: 118215) and anti-CD133-phycoerythrin (PE) (Miltenyi Biotec, CA, USA; 
catalogue number: 130-092-334) mouse monoclonal antibodies at 1:100 dilution on 
ice for 10min in dark. The staining procedure was carried out in 50ul and the binding 
reaction was quenched with 1ml of PBS.  
 
2.4 Flow cytometry analysis and fluorescence-activated cell sorting (FACS) 
Cells stained by Hoechst 33342 and/or flurochrome-conjugated antibodies 
were counterstained with 1µg/ml of propidium iodide (PI) before analysis and/or 
FACS enrichment on FACSVantageTM cell sorter (BD Biosciences, CA, USA) or 
FACSAria Special Order cell sorter (BD Biosciences, CA, USA) or LSRII Special 
Order (BD Biosciences, CA, USA). Hoechst 33342 dye was excited by 350nm UV 
laser and its fluorescence was measured at two wavelengths using 450/20nm band-
pass (BP; Hoechst blue) and 675nm long-pass (LP; Hoechst red) optical filters. 
Fluorescence signals of EpCAM-PE-Cy7 and CD133-PE were measured by 
785/50nm and 585/42nm detectors on FACSVantageTM or LSRII Special Order. The 
same machines were used to enrich or analyse lentivirus-infected cells that express 
enhanced green fluorescent protein (EGFP), measured by 530/30nm detector. Flow 




2.5 Purification of RNA 
Cells were washed with PBS and resuspended in 350µl of RLT lysis buffer 
containing 1% β-mercaptoethanol. RNA extraction was performed using RNeasy 
Mini Kit and RNase-free DNase Set (QIAGEN, Hilden, Germany) following 
manufacturer’s protocol. Briefly, cell lysates were homogenised by vortexing for 1 
minute, followed by addition of 70% ethanol and transferred to RNeasy spin column. 
On column digestion of genomic DNA was carried out using 80µl of DNase I 
incubation mix. The spin column was then washed with buffers RW1 and RPE, 
followed by a final spin to remove residual ethanol. RNA was subsequently eluted in 
30-50µl of RNase-free water and quantified by NanoDrop 1000 Spectrophotometer 
(Thermo Fisher Scientific, MA, USA).  
 
2.6 Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) 
Complementary DNA (cDNA) was synthesized from 0.1-1.0µg of total RNA 
using Omniscript reverse transcription (RT) kit (QIAGEN, Hilden, Germany) in a T3 
Thermocycler (Biometra, DE UK). The reaction mixtures were incubated at 37oC for 
70min and the Omniscript reverse transcriptase was inactivated at 95oC for 5min. 
Quantitative PCR was performed in 7500 Real-time PCR system using 1µl of cDNA 
and TaqMan Universal PCR Master Mix or Power SYBR Green Master Mix (Applied 
Biosystems, CA, USA). TaqMan gene expression probes for Lgr5 and Gapdh are 
Mm00438890_m1 and Mm99999915_g1 respectively. The list of gene-specific 




Table 2.1. List of SYBR Green primers for qRT-PCR. 
 
2.7 Nude mice transplantation assay 
BALB/c female nude mice were purchased from Biopolis Resource Centre 
(BRC; A*STAR, Singapore) and all procedures performed were in accordance with 
BRC Institutional Animal Care and Use Committee guidelines. GIF-14 clonal lines or 
FACS-purified cells were resuspended in 200µl of PBS and were injected 
subcutaneously into 7-8 weeks or 12-13 weeks old immuno-compromised nude mice. 
Tumour development was monitored weekly and the tumour sizes were scored. The 
diameters of the tumours were determined using rulers and the tumour volumes were 
calculated by the formula 4/3pir3 where r represents the radius of tumour. Animals 
were culled when tumour sizes reached 15mm in diameter.  
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2.8 Soft agar colony assay 
FACS-isolated cells were suspended in DMEM supplemented with 0.4% 
agarose and 10% FBS, and seeded at clonogenic densities over a basement layer of 
0.6% agarose. The experiments were set up in 6-well plates at 200,000 and 500,000 
cells/well in triplicates. Colonies of ≥150µm in size were scored after 3 weeks of  
culture at 37oC in a humidified atmosphere containing 5% CO2. Photographs of 
representative colonies were taken using Nikon Eclipse TS100 phase-contrast 
microscope (Nikon Corporation, Tokyo, Japan). 
 
2.9 Sphere-forming assay 
FACS-enriched cells were seeded at clonogenic densities in 6-well ultra-low 
attachment plates (Sigma-Aldrich, MO, USA) at 2500 cells/well. The cells were 
cultured in serum-free DMEM:F12 medium (Invitrogen, CA, USA) consisting of 
20ng/ml of human recombinant EGF (PeproTech, NJ, USA), 10ng/ml of human 
recombinant bFGF (Invitrogen, CA, USA), 1x B27 (Invitrogen, CA, USA), 1x N2 
(Invitrogen, CA, USA), 1ng/ml of hydrocortisone (StemCell Technologies, CA, USA), 
5µg/ml of insulin (Invitrogen, CA, USA) and 0.4% bovine serum albumin (BSA) 
Fraction V (Sigma-Aldrich, MO, USA). Methylcellulose (Sigma-Aldrich, MO, USA) 
was added to a final concentration of 0.1-1.0% to prevent cell aggregation. The 
number of spheres/well were counted at the indicated time after culturing. To generate 
secondary spheres, primary spheres were harvested by centrifugation at 500rpm for 
2min and dissociated to single cells by TrypLE Express (Invitrogen, CA, USA) for 7-
10min. Digestion was inactivated by DMEM supplemented with 0.4% BSA. The cells 
were sieved through 40µm nylon mesh (BD Biosciences, CA, USA) and seeded at 
2500 cells/well in sphere medium. Images of representative spheres were captured 
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using Nikon Eclipse TS100 phase-contrast microscope (Nikon Corporation, Tokyo, 
Japan). 
 
2.10 Time-lapse videomicroscopy 
FACS-purified P1 and P2 cells were seeded at clonogenic densities on 25mm 
glass cover slips (Marienfeld Superior, Lauda-Koenigshofen, Germany) or low 
evaporation 6-well plates (BD Biosciences, CA, USA). Following colony formation, 
the glass cover slips were transferred to Sykes Moore (BellCoGlass, NJ, USA) 
chamber with complete CO2-independent medium (Invitrogen, CA, USA), while 
those grown in 6-well plates were replenished with standard growth medium. Sykes-
Moore microperfusion chamber or 6-well plate was placed into a culture chamber 
(PeCon, Erbach, Germany) and mounted on Nikon Ti Eclipse microscope (Nikon 
Corporation, Tokyo, Japan) and maintained at 37oC and 5% CO2 throughout the 
experiment. Colonies on glass slips and 6-well plates were visualised at 100x 
magnification by differential interference contrast (DIC) microscopy or phase contrast 
microscopy respectively. DIC images of P1 and P2 colonies were captured by a HQ2 
CCD camera (Photometrics, AZ, USA) at 3min intervals over 18h. For samples 
subjected to TGF-β1 treatment, DIC and phase contrast images of P1 colonies were 
captured before and after 2.5ng/ml of TGF-β1 treatment at 5min intervals for the 
indicated timeframes. These images were processed using Metamorph (Molecular 
Devices, CA, USA) and VirtualDub (http://www.virtualdub.org/) softwares for the 
construction of time-lapse movies.  
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2.11 Immuno-fluoresent staining 
P1 and P2 colonies were generated on coverslips by seeding cells at 
clonogenic densities. Once the colonies were formed, P1 colonies were pre-treated 
with 10µM of TGF-β inhibitor, SB431542 (TOCRIS Bioscience, Bristol, UK) for 15h 
prior to 48h of TGF-β1 treatment at 2.5ng/ml. Colonies were fixed using 4% 
paraformaldehyde and permeablised with 0.5% Triton X-100. After blocking with 1% 
BSA, the colonies were incubated with anti-β-catenin (Sigma-Aldrich, MO, USA; 
clone 6F9; catalogue number: C7082), anti-desmoplakin (Millipore, MA, USA; clone 
DP2.15; catalogue number: CBL173), anti-Smad2/3 (BD Transduction, CA, USA; 
clone 18; catalogue number: 610843), or anti-phospho-Smad2/3 (Santa Cruz, CA, 
USA; catalogue number: sc-11769-R) primary antibodies at 1:200 dilution for 1h at 
room temperature. This was followed by addition of Alexa Fluor 488-conjugated anti-
mouse (Invitrogen, CA, USA; catalogue number: A-11001) or Cy3-conjugated anti-
rabbit (Invitrogen, CA, USA; catalogue number: 10520) secondary antibodies at 
1:500 dilution for 45min at room temperature. F-actin was visualised using phalloidin 
conjugated to Alexa Fluor 350 (Invitrogen, CA, USA; catalogue number: A22281) at 
1:50 dilution. The stained colonies were mounted on glass slides using ProLong Gold 
Antifade reagent (Invitrogen, CA, USA). Images were captured using Nikon Ti 
Eclipse confocal microscope (Nikon Corporation, Tokyo, Japan) or Leica 6000B 
epifluorescence microscope (Leica, Wetzlar, Germany) and processed using 
MetaMorph software (Molecular Devices, CA, USA).  
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2.12 Cloning of RUNX3 and RUNX3R178Q into lentiviral vectors 
2.12.1 Polymerase chain reaction (PCR) amplification 
The p44 isoform of human RUNX3 and RUNX3R178Q cDNAs were PCR-
amplified from pcDNA-FLAG-RUNX3 (Bae et al., 1995) and pcDNA-FLAG-
RUNX3R178Q encoding the DNA-binding defective form of human RUNX3 (Inoue et 
al., 2007). PCR amplification was performed in a 50µl reaction mixture containing 
1.25U of Platinum Pfx DNA polymerase (Invitrogen, CA, USA), 1X Pfx 
amplification buffer, 1.5 mM MgSO4, 0.3 mM of each dNTP (Finzymes, Espoo, 
Finland), 0.4µM of forward primer (5’-AAAAAAGAATTCATGCGTATTCCCGTA 
GACCCAAGCACCAGC-3’) and 0.4µM of reverse primer (5’-AAAAAAGCGGCC 
GCTCAGTAGGGCCGCCACACGGCCTCATCC-3’). The PCR cycling parameters 
consisted of 35 cycles at 95oC for 30s, 56oC for 30s and 72oC for 2min. Final 
extension at 72oC for 15min was performed. PCR products were analysed by agarose 
gel electrophoresis and the bands of correct sizes were excised and recovered with the 
QIAquick gel extraction kit following manufacturer’s protocol (QIAGEN, Hilden, 
Germany). The PCR products were cloned immediately upstream of IRES-EGFP via 
engineered 5’ EcoRI and 3’ NotI sites in the LeGO-iG2 plasmid (termed iG2), a 
bicistronic lentiviral vector generated by Weber et al., 2008. The ligation of digested 
PCR products and linearised iG2 vector was performed for at least 1h at room 
temperature using T4 DNA ligase (NEB, MA, USA) in a 20µl reaction containing 1µl 
of DNA ligase. The utilisation of internal ribosome entry site (IRES) in the iG2 
lentiviral vector enables co-expression of RUNX3/RUNX3R178Q and EGFP in the 
transduced cells driven by the spleen focus-forming virus (SFFV) promoter. Similarly, 
wild-type RUNX3 and RUNX3R178Q cDNAs were cloned into a modified pBOBI 
lentiviral vector (a kind gift of Dr Vinay Terganonar, Institute of Molecular and Cell 
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Biology, A*STAR, Singapore) using 5’ XbaI and 3’ XhoI sites. The cloning of 
RUNX3 and RUNX3R178Q into the lentiviral vectors was performed by Dr Dominic 
Voon (Cancer Science Institute of Singapore, National University of Singapore, 
Singapore). 
 
Figure 2.1. Plasmid map of the LeGO-iG2 lentiviral vector. CMV (promoter): cytomegalovirus; SFFV 
(promoter): spleen focus-forming virus; IRES: internal ribosome entry site; eGFP: enhanced green 
fluorescent protein. Unique restriction sites present in the vector are marked in blue. 
 
2.12.2 Chemical transformation of Escherichia coli 
Three microlitres of ligated products was transformed into 50µl of home-made 
chemically-competent Escherichia coli XL10-Gold strain originally obtained from 
Stratagene (CA, USA). The mixture was kept on ice for 30min prior to heat-shock at 
42oC for 80s. The mixture was returned to ice immediately for 5min and recovered in 
200µl Luria-Bertani (LB) medium at 37oC with shaking for 1h. The transformation 
mixture was subsequently plated onto LB agar plates containing 100µg/ml of 
ampicillin (Sigma-Aldrich, MO, USA) and incubated overnight at 37oC for selection 
of successfully transformed bacterial cells.  
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2.12.3 Purification of plasmid DNA 
DNA purification was performed at small-scale from 3ml of starter cultures 
with QIAprep Spin Miniprep columns (QIAGEN, Hilden, Germany) or large-scale 
from 50ml of overnight cultures with QIAfilter Plasmid Midi kit (QIAGEN, Hilden, 
Germany) according to manufacturer’s protocols. The amount of DNA yielded was 
measured using NanoDrop 1000 Spectrophotometer (Thermo Fisher Scientific, MA, 
USA).  
 
2.12.4 Sequencing of plasmid DNA 
Clones of recombinant plasmid DNA were fully sequenced using BigDye 
Terminator version 3.1 Cycle Sequencing kit (Applied Biosystems, CA, USA). Each 
sequencing reaction was made up of 300ng of plasmid DNA, 3.2pmol of the forward 
or reverse primer (Section 2.12.1), 8µl of Terminator Ready Reaction Mix and H2O to 
a final volume of 20µl. PCR was carried out in 96-well GeneAmp PCR System 9700 
(Applied Biosystems, CA, USA). The PCR reaction involved an initial denaturation at 
95oC for 3min and 35 cycles at 95oC for 30s, 52.5oC for 10s and 60oC for 4min. 
Purification and subsequent sequencing of the PCR products were carried out by the 




2.13 Lentivirus production and transduction 
Lentiviruses were produced according to the protocol described in Tiscornia et 
al., 2006 with minor modifications. Briefly, 0.7x106 HEK293T cells were seeded on a 
6-well plate pre-coated with 0.001% of poly L-lysine (Sigma-Aldrich, MO, USA) one 
day before transfection. iG2- or pBOBI-Control, -RUNX3 or -RUNX3R178Q transfer 
vectors (1µg) were co-transfected into HEK293T cells with third generation 
packaging plasmids containing pLP/VSVG (1µg), pLP1 gag/pol (0.66µg) and pLP2 
Rev (0.33µg) (ViraPower Lentiviral Expression system; Invitrogen, CA, USA) using 
10µl of FuGENE HD (Roche, Basel, Switzerland). The cells were washed with PBS 
8h post-transfection and replaced with fresh DMEM supplemented with 15% FBS 
(HyClone Laboratories UT, USA). The supernatants containing viral particles were 
harvested at 24h and 48h post-transfection. For transduction with iG2-based 
lentiviruses, GIF-14 cells cultured in 6-well tissue culture plates at 80% confluency 
were incubated with virus-containing supernatants in 1:3 ratio to culture media in the 
presence of 5µg/ml of polybrene (Sigma-Aldrich, MO, USA) for 24h before 
replenishment with fresh culture medium. Infected cells were either subjected to 
Hoechst/antibody staining or treated with Wnt3a-Cm or TGF-β1 prior to enrichment 
by FACS. Transduction with pBOBI-based lentiviruses was performed in a similar 
manner in 48-well tissue culture plates and the cells were harvested in situ following 
15h of Wnt3a-Cm treatment.  
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2.14  Protein preparation and Western blotting 
Runx3+/+ (GIF-9 and GIF-13) and Runx3-/- (GIF-5 and GIF-14) cells were seeded in 
15-cm tissue culture dishes and harvested at 80% confluency for Western blot 
analysis. Cell pellets were lysed by urea lysis buffer (9M of urea, 2% of Triton-X-100 
and 5% of β−mercaptoethanol) supplemented with 1x Complete protease inhibitor 
(Roche, Basel, Switzerland) and 10mM of phenylmethylsulfonyl fluoride. Transduced 
GIF-14 cells were lysed by RIPA buffer (50mM Tris-HCl pH 7.4, 150mM NaCl, 1% 
NP-40, 0.25% sodium deoxycholate and 1mM EDTA) in a similar manner. Sonication 
was then performed using Bioruptor (Diagenode, NJ, USA) to shear the genomic 
DNA to disrupt large protein-DNA complexes, allowing proteins to fully solubilise. 
The cell lysates were centrifuged at 10,000 rpm for 10min and the supernatants were 
collected into fresh microfuge tubes. The amount of protein was quantified using 
Bradford Assay. Briefly, 2µl of cell lysate was mixed with 1.98ml of 1X Bradford dye 
and incubated for 5min at room temperature prior to measurement using GeneQuant 
1300 spectrophotometer (GE Healthcare, Little Chalfont, UK). After quantification, 
the amount of proteins was normalised against the most diluted sample before the 
addition of SDS-containing loading buffer. Cell lysates were heated at 370C for half 
an hour to denature the proteins. Whole cell lysates were resolved in 10% SDS-
polyacrylamide gels and electrophoresed at 170V and 40mA for approximately 2.5h. 
Proteins were transferred onto PVDF membranes (Biorad, CA, USA) at constant 
100V for 1 h 45 min prior to blocking using 5% skim milk in PBST (PBS + 0.1% 
Tween) (Fonterra, AU, New Zealand) for 1h. Murine Runx3 was detected using two 
separate anti-RUNX3 monoclonal antibodies, R3-5G4 and R3-8C9 (a kind gift of 
Kotaro Tada) at 1µg/ml in PBST + 1% skim milk and PBST + 2.5% skim milk, 
respectively. Human RUNX3 was detected using R3-5G4 antibody. Detection of the 
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housekeeping protein, α-tubulin was performed by incubation with anti-α-tubulin 
antibody (Sigma-Aldrich, MO, USA) at 1:50000 dilution for 1h. Membranes were 
washed for 3 times with PBST buffer before incubation with HRP-conjugated anti-
mouse secondary antibody (GE Healthcare, Little Chalfont, UK) at 1:8000 dilution in 
PBST + 5% skim milk for 1h. After removing excess secondary antibody, 
chemiluminescent signals were captured using Immobilon Western 
Chemiluminescent HRP substrate reagents (Millipore, MA, USA).  
 
2.15 Statistical analysis 
All data performed in replicates are presented with standard error mean (SEM). 
When two data sets were compared, the Student’s t-test was used and p-values < 0.05 
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3.1.1 Cell immortalisation and transformation  
Cancer is a multi-step process driven by the sequential accumulation of 
mutations in critical genes such as oncogenes and tumour suppressors. Genetic 
alterations of these genes lead to uncontrolled cell proliferation, resistance to 
apoptosis, and acquisition of other traits associated with the malignant cell phenotype 
(Drayton and Peters, 2002). This process usually takes a period of decades. During 
tumour formation, human cells need to undergo an abnormally long succession of 
growth-and-division cycles in order to complete the steps of tumorigenesis. In the 
current model of this process, the first step is the ability of cells to replicate 
indefinitely, termed immortalisation (Weinberg, 2007). Immortalised cells are pre-
malignant but non-tumorigenic. They are susceptible to cellular transformation upon 
further genetic hits to become tumorigenic. 
Cellular immortalisation and transformation has been intensively studied in 
vitro, most commonly in murine embryonic fibroblasts (MEFs). These studies have 
offered fundamental insights into the biology of carcinogenesis. Under normal 
culturing conditions, MEFs would rapidly cease to proliferate after several passages in 
response to stress (Parrinello et al., 2003). Immortality could be achieved by ectopic 
expression of a number of oncogenes, such as the large T oncoprotein of Simian virus 
40 that inactivated the function of primary negative regulators of cell cycle, p53 and 
pRb (Schreier and Gruber, 1990). Accordingly, mutations of either p53 or its targets 
p16INK4a/p19ARF were frequently found in spontaneously immortalised NIH3T3 MEFs 
(Linardopoulos et al., 1995). In addition, forced expression of the catalytic component 
of human telomerase in some cell types led to the generation of immortalised cell 
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lines (Bodnar et al., 1998). In order for immortalised cells to become fully 
transformed, additional mutations are needed, typically through the introduction of an 
oncogene such a constitutively activate H-Ras mutant (Visvanathan et al., 1998). 
Immortalisation and transformation could also be achieved through the introduction of 
oncogenes found in DNA tumour viruses. Middle T and large T oncogenes from 
polyomavirus collaborate with one another to transform rodent cells. The large T 
oncoprotein facilitates immortalisation while the middle T oncoprotein elicits many 
functions associated with the Ras oncogene to confer full transformation 
(Rassoulzadegan et al., 1982). Therefore, much of the process of tumorigenesis could 
be revealed through these studies. 
Classically, there are several experimental approaches to determine successful 
transformation. A particularly common benchmark used in the assessment of 
tumorigenicity in vivo is the subcutaneous transplantation of transformed cells into 
immuno-compromised animals such as the athymic nude mice (Flanagan, 1966). 
Immuno-deficient mice are incapable of mounting immune response against grafted 
cells. Tumorigenicity is measured by the ability of transplanted cells to form tumours 
in mice. As transplantation assays are typically time consuming and lengthy, rapid 
and quantitative in vitro assays have been developed to evaluate tumorigenicity. One 
of the key properties of transformed cells is anchorage-independent growth in which 
cells are able to proliferate without attachment to solid substratum (Cifone and Fidler, 
1980). The soft agar colony formation assay is used to monitor anchorage-
independent growth in a semi-solid agar medium. Cells that have the capability to 
grow as colonies under such conditions are considered tumorigenic. However, the 
initial set-up and final scoring of colonies can be labour-intensive. Although each of 
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these methodologies has its caveats and limitations, they are useful functional assays 
to measure tumorigenic potential.  
 
3.1.2 Strategies for identifying tumour-initiating cells 
In this study, immortalised gastric epithelial (GIF) cell lines were established 
from mouse embryos through genetic disruption of p53. As these cell lines were 
immortalised but not transformed, they were not expected to be tumorigenic. 
However, owing to the loss of the gastric tumor suppressor Runx3, Runx3-/-.p53-/- GIF 
cell lines formed tumours when transplanted into immuno-compromised nude mice 
(Fukamachi et al., 2004). Notably, the tumorigenic potential of Runx3-/-.p53-/- GIF cell 
lines was inherently low as the cell number necessary for generating tumour was 
typically 10E4 higher than standard transformed cells (Fukamachi et al., 2004). These 
observations indicate that Runx3 deficiency moved the cells one step closer to 
tumorigenesis even though full transformation did not occur. To further understand 
the underlying molecular mechanisms of the tumorigenicty of Runx3-/-.p53-/- cells, we 
sought to identify and characterise the properties of these tumorigenic cells in Runx3-/-
.p53-/- GIF cell lines.  
Recently, the hypothesis that cancer is driven and maintained by a small 
subpopulation of cancer cells within the tumour mass has gained attention in the 
tumour biology field (Lapidot et al., 1994). This subpopulation is often referred to as 
“cancer stem cells” (CSCs). CSCs demonstrate increased resilience against 
conventional chemotherapy and are thought to be responsible for tumour recurrence 
and maintenance. There is also evidence suggesting that CSCs are involved in 
metastasis of solid tumours (Velasco-Velazquez et al., 2011). Therefore, cancer stem 
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cells hold promise as novel cellular targets for the treatment of malignancies (Reya et 
al., 2001). CSCs are experimentally defined by the ability to regrow the tumour in 
immuno-compromised mice from which they were isolated or identified (Lapidot et 
al., 1994). Thus, the term tumour-initiating cells (TICs) are frequently used as it more 
closely reflects the experimental evidence. In this chapter, TICs would be used to 
describe cells bearing cancer stem cell properties. The TICs in tumours are identified 
by the use of molecular markers expressed on the cell surface, which were first 
discovered to enrich for stem cells. In the hematopoietic system, purification of tissue 
stem/progenitor cells relies largely on cell surface markers, which can serve as either 
positive or negative makers for stem/progenitor cell activity (Challen and Little, 2006). 
Often, a combination of several cell surface markers is required to achieve high 
degree of enrichment of stem/progenitor cells as none of these cell surface markers is 
expressed exclusively on stem/progenitor cells. Although the use of cell surface 
markers does confer specificity to the identification and isolation of normal 
stem/progenitor cells and TICs, this strategy fails in the absence of known cell surface 
markers (Wu and Alman, 2008). Unfortunately, cell surface markers that define TICs 
are not well characterised in many solid tumours, including those in gastric cancers.  
In the last decade, the Hoechst 33342 staining technique has gained popularity 
in the study of tissue stem cells as it is a versatile tool to identify, purify and 
characterise resident tissue stem/progenitor cells independent of cell surface markers. 
This method is simple and particularly useful when the stem/progenitor cells are not 
well characterised by cell surface markers. Based on differential staining by the 
Hoechst 33342 dye, this technique has facilitated the enrichment of stem/progenitor 
cells in a variety of normal tissues including blood, skin, lung, liver, heart, mammary 
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gland and skeletal muscle (Wu and Alman, 2008). Hoechst 33342 is a fluorescent dye 
that binds to AT-rich DNA and can be excited by ultraviolet laser. Its fluorescence is 
plotted at two emission wavelengths using 450/20nm band-pass (Hoechst blue) and 
675nm long-pass (Hoechst red) filters on the flow cytometer. When first established 
in the analyses of murine bone marrow cells, it was found that cells dimly stained by 
the Hoechst 33342 dye were strongly enrich for long-term repopulating hematopoietic 
stem cells (Goodell et al, 1996). These cells were termed the “side population” (SP) 
as they resolved to the “side” of the bulk of more strongly stained cells in FACS 
analysis (Figure 3.1; Challen and Little, 2006). The mechanism regulating the efflux 
of Hoechst 33342 dye is partly conferred by the expression of ATP binding cassette 
protein transporters. Forced expression of these membrane-bound transporters such as 
Abcg2/Bcrp1 and Abcb1/MDR1 in murine bone marrow cells resulted in an expansion 
of SP in vitro and increased long-term repopulating hematopoietic stem cells in vivo 
(Bunting et al, 2000; Zhou et al., 2001). Therefore, when Hoechst 33342 staining was 
performed in the presence of an inhibitor of ATP binding cassette protein transporters, 
verapamil, SP cells were ablated (Figure 3.1; Challen and Little, 2006). The gate for 
the SP is set to demarcate the cell population specifically eliminated upon the 
treatment of verapamil as shown in Figure 3.1 (Challen and Little, 2006). However, a 
gradient of dye efflux exists within the SP in which the cells at its tip possessed the 
highest efflux while the cells at the top of the SP display least efflux, as reflected in 
the increasing Hoechst 33342 fluorescence intensity. It was found that the cells with 
the greatest dye efflux capability exhibited the highest long-term hematopoietic stem 
cell activity within the SP (Goodell et al., 1997). Due to the superior enrichment of 
stem cells, a small gate is usually applied to capture the cells at the tip of the SP for 
functional characterisations and comparative analyses. 
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Figure 3.1. Flow cytometry profile of murine bone marrow cells after staining with Hoechst 33342. (A) 
The SP appeared as the Hoechst 33342 low fraction capable of pumping out the dye more efficiently 
than the bulk of the Hoechst 3342 high cells. (B) The SP was ablated when verapamil was added in the 
Hoechst 33342 incubation. This figure was taken from Challen and Little, 2006. 
 
Subsequently, the Hoechst 33342 staining method has been utilised to identify 
and isolate TICs in many human cancer cell lines and primary tumours (Wu and 
Alman, 2008). Several studies have shown highly enriched tumour-initiating activity 
for the SP cells purified from hepatocellular, lung, brain, gastrointestinal and 
nasopharyngeal carcinoma cell lines, compared to both the bulk tumour cell 
population and the non-SP population (Kondo et al., 2004; Chiba et al., 2006; 
Haraguchi et al., 2006; Ho et al., 2007; Wang et al., 2007).  
It has been reported that TICs share several properties with normal stem cells, 
especially the capability of self-renewal (Pardal et al., 2003). The sphere-forming 
assay is a standard in vitro assay frequently utilised to characterise normal tissue stem 
cells and TICs in the brain and mammary glands (Weiss et al., 1996;  Al-Hajj et al., 
2003; Dontu et al., 2003; Kondo et al., 2004). Stem cell-like properties are 
demonstrated by the formation of spheres on non-adherent surfaces in serum-free 
culture medium. The ability to generate spheres depends on the presence of 
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stem/progenitor cells within a cell population. Cells that form spheres, which can be 
serially passaged are believed to possess self-renewal properties (Dontu et al., 2003).  
 
3.1.3 Experimental approach 
The experiments described in this chapter are aimed to identify and isolate the 
tumorigenic cells from a Runx3-/-.p53-/- GIF cell line (GIF-14) by employing the 
Hoechst 33342 staining technique. These cells are tested for their tumorigenic 
potential using transplantation and soft agar colony formation assays. Furthermore, 
gene expression profiling for stem-cell-related markers and sphere-forming assays 






3.2.1 Hoechst 33342 staining of GIF-14 cells revealed two distinct subpopulations 
Hoechst 33342 staining was performed on a Runx3-/-.p53-/- GIF cell line, GIF-
14, to separate the cells based on their dye exclusion capability. To obtain a 
reproducible Hoechst 33342 staining pattern, a series of optimisations were 
previously performed for various Hoechst 33342 concentrations, incubation time and 
verapamil concentrations. Figure 3.2 shows a typical flow cytometric profile of GIF-
14 cells following staining with Hoechst 33342 under the optimised conditions. GIF-
14 cells could be seen as two major subpopulations, P1 and P2 with significantly 
different fluorescence owing to differential dye efflux properties. The P1 
subpopulation had relatively lower fluorescence as they excluded dye efficiently. This 
lower fluorescence was effectively blocked by verapamil as the cells were unable to 
efflux the dye resulting in increased intracellular Hoechst 33342 concentrations. 
Therefore, the P1 subpopulation was defined by the cell population that had shifted 
upon the treatment of verapamil, the majority of which could be analysed by marking 
a large gate as depicted in Figure 3.2. In contrast, the P2 subpopulation was defined 
by high fluorescence due to its lower dye pumping capacity, and that its staining 





Figure 3.2. Hoechst 33342 staining of Runx3-/- GIF-14 cells revealed two distinct subpopulations. GIF-
14 cells were stained by 10µg/ml of Hoechst 33342 in the absence and presence of 4µg/ml of verapamil 
as described Section 2.3. Hoechst fluorescence is plotted at Hoechst blue (450/20nm BP filter) and 
Hoechst red (675nm LP filter) on the flow cytometer. The gate for P1 is set to encompass majority of the 
cells which are sensitive to verapamil treatment. 
 
3.2.2 P1 and P2 cells display differential EpCAM and CD133 expressions 
 To determine the relative expression of cell surface markers in P1 and P2 
subpopulations, GIF-14 cells were simultaneously stained by Hoechst 33342 and 
antibodies against various cell surface antigens which are known to mark 
differentiation status in different tissues (Table 3.1). The expression levels of the 
tested cell surface markers in P1 and P2 subpopulations are summarised in Table 3.2. 
Surface marker profiling revealed that the expression of CD133, EpCAM, and CD49f 
were substantially higher in P1 compared with P2 (Table 3.2). However, P1 and P2 
subpopulations did not show obvious difference in the expression of other cell surface 









Table 3.2. Summary of expression levels of cell surface antigens in P1 and P2 subpopulations. GIF-14 
cells were co-stained by Hoechst 33342 and various antibodies against cell surface antigens and 
analysed by flow cytometry. The percentage of positivity of each surface marker in total GIF-14 cells, P1 




EpCAM is expressed on the cell surface membrane of virtually all epithelial 
cells and hence is generally regarded as an epithelial marker (Latza et al., 1990). 
Despite being widely expressed in many adenocarcinomas (Latza et al., 1990), its 
expression in gastric cancer tissues is not well studied. Similar to EpCAM, the 
involvement of CD49f in gastric tumours is obscure. It is known that CD49f forms 
heterodimers with the integrin β4 subunit which acts as the receptor for laminin in all 
epithelial cells (Krieger et al., 2004).  CD133 is not only expressed in organ-specific 
stem cells, but also in differentiated epithelial cells in the liver, pancreas and colon 
(Weigmann et al., 1997; Florek et al., 2005, Shmelkov et al., 2008). Our results 
revealed that these three cell surface markers, which are prominently expressed in 
epithelial cells, were depleted in the P2 subpopulation, suggesting that P2 cells have 
reduced epithelial cell characteristics compared to P1 cells. Such differences in 
epithelial cell differentiation status may have implications in the relative tumorigenic 
potential of P1 and P2 subpopulations. 
Co-staining of antibodies against EpCAM and CD133 together with Hoechst 
33342 in the GIF-14 cell line was performed. For flow cytometric analyses, a large P1 
gate was set in order to include the majority of P1 cells to ensure the relative 
expressions of EpCAM and CD133 is representative of P1 cells. The results showed 
that the P1 subpopulation displayed EpCAMhighCD133+ expression pattern while the 
P2 subpopulation was demarcated by EpCAMlowCD133- antigen profile (Figure 3.3 
top panel). Conversely, EpCAMhighCD133+ and EpCAMlowCD133- fractions enriched 
for P1 and P2 subpopulations, respectively (Figure 3.3 bottom panel). Therefore, the 
above data indicate that P1 and P2 represent distinct subpopulations of varied 




Figure 3.3. Double staining of EpCAM/CD133 with Hoechst 33342 in GIF-14 cells. Hoechst 33342-
stained GIF-14 cells were co-stained by antibodies against EpCAM and CD133. Cells were then 
subjected to flow cytometry. The distribution of EpCAM and CD133 within P1 and P2 subpopulations 
(top panel) and the Hoechst 33342 profiles of EpCAMhighCD133+ and EpCAMlowCD133- fractions were 










3.2.3 The P2 subpopulation forms tumours more readily than the P1 subpopulation 
Staining of GIF-14 cells by Hoechst 33342 enables the purification and 
functional characterisation of P1 and P2 subpopulations. To test their relative 
tumorigenicities in vivo, these two subpopulations were allografted into the immuno-
compromised nude mice. These transplantation experiments were performed in two 
complementary approaches using: 1) FACS-fractionated P1 and P2 cells isolated from 
parental GIF-14 culture, and 2) clonal lines established from enriched P1 and P2 
subpopulations. In the first experiment, P1 and P2 subpopulations were sorted from 
parental GIF-14 line by FACS and briefly cultured in vitro for recovery and 
expansion. Purified P1 and P2 cells were analysed by Hoechst 33342 staining to 
confirm that they maintained their respective staining patterns prior to transplantation 
into nude mice (Figure 3.4). For each tested subpopulation, cells were transplanted 
subcutaneously into hind flanks of each mouse. Unsorted parental GIF-14 cells were 
similarly injected in the neck region of the same mouse to act as a control. Two 
independent transplantations using 4x 106 and 2x 106 cells were performed. In both 
experiments, the P2 subpopulation was observed to form tumours more readily in 
nude mice than the P1 subpopulation. This was reflected in the higher tumour 
incidence and greater tumour size (Figure 3.5).  
 
Figure 3.4. Hoechst 33342 staining profiles of sorted P1 and P2 subpopulations. P1 and P2 cells were 
purified by FACS and expanded in culture for about 1 week. Hoechst 33342 staining was performed on 




        
 








Figure 3.5. Relative tumorigenicity of FACS-enriched P1 and P2 cells in nude mice allografts. Top plot: For 
each mouse, 4x 106 of sorted P1 (left hind flank), sorted P2 (right hind flank) and unsorted (neck) cells 
were injected and tumour sizes were scored after 8 weeks (n=5). Age of mice was 12-13 weeks. Bottom 
plot: Independent but similar experiment in which 2x 106 cells were transplanted and the tumours were 
examined after 11.5 weeks (n=9). Age of mice was 7-8 weeks. Each dot on the plots represents tumour 
size from a single mouse. Black horizontal bars denote the mean tumour volume for each cell population. 
Tumour volume was calculated by the formula 4/3pir3 where r is tumour radius. Student’s t-test was 
performed and single asterisk represents p-value <0.05. Tabulation of the number and diameter of tumours 




P1 and P2 clonal lines were raised from purified P1 or P2 cells through single-
cell cloning in 96-well plates. Nine P1 and twelve P2 single-cell clones were obtained 
and three clonal lines derived from each subpopulation were analysed for the 
maintenance of their Hoechst 33342 staining patterns. The results for a representative 
clonal line derived from P1 or P2 subpopulation were shown in Figure 3.6. P1 and P2 
clonal lines preserved their respective Hoechst 33342 profiles preceding 
transplantation in nude mice in a similar manner as described earlier. Consistent with 
the results from sorted pooled cells, the tested P2 clonal line was significantly more 
tumorigenic than the P1 clonal line both in terms of the frequency of tumour initiation 
and tumour size (Figure 3.7). Thus, we conclude that the tumour-initiating cells reside 
largely in the low dye effluxing, EpCAMlowCD133- P2 subpopulation within the GIF-
14 cell line.  
 
Figure 3.6. Hoechst 33342 staining of P1 and P2 clonal lines. FACS-purified P1 and P2 cells were 
seeded at clonagenic density in 96-well plates and colonies were raised from single P1 or P2 cells. 












Figure 3.7. Comparison of the tumorigenic potential of P1 and P2 clonal lines. For each mouse, 2x 106 
of P1 clone2 (left hind flank), P2 clone3 (right hind flank) and unsorted (neck) cells were inoculated and 
tumours were harvested after 14 weeks (n=10). One mouse had no tumour at all sites. Age of mice was 
7-8 weeks. Each dot on the plots signifies tumour size from one mouse. Black horizontal bars represent 
the average tumour sizes for each cell population. Student’s t-test was performed and single asterisk 
represents p-value <0.05. Tumour number and size are tabulated in the table next to the graph. 
 
3.2.4 P2 cells form colonies more readily in soft agar assay 
FACS-enriched P1 and P2 cells were further evaluated for their ability to 
exhibit anchorage-independent growth in vitro by soft agar assay. The isolated cell 
populations were suspended at clonogenic density in agar mixed with normal culture 
medium and colony formation was determined. Control sorted cells were all the cells 
collected within the FACS plot including P1 and P2 subpopulations. Consistent with 
the transplantation data, P2 cells formed colonies far more readily than P1 cells, 
reflecting greater tumorigenicity (Figure 3.8). The colonies were scored manually 
using a microscope as they were generally small. This reflects the low tumorigenicity 




Figure 3.8. Comparison of anchorage independent growth of sorted P1 and P2 cells. FACS-fractionated 
P1, P2, control sorted and unsorted parental GIF-14 cells were subjected to soft agar assay to assess 
the relative anchorage independent growth potential. Control sorted cells represents the total population 
within the entire FACS plot. After 3 weeks of culture, colonies ≥150µm in size were scored and the data 
are represented as means ± standard error mean (SEM) (n=3). Double asterisks denotes p-value <0.01. 
Representative phase contrast images of the colonies were taken from samples with 200,000 cells/well. 
Scale bars, 200µm.  
 
3.2.5 The P2 subpopulation is enriched for stem cell-related genes 
To ascertain whether the tumorigenic P2 subpopulation shares attributes of 
stem cells, gene expression profiling was performed to measure the transcript levels 
of stem cell-related markers by quantitative RT-PCR (qRT-PCR). In order to perform 
the most effective comparison in the gene expression between P1 and P2, a small gate 
was applied to capture the highest dye-effluxing P1 cells as shown in Figure 3.9 left 
panel. This ensures that fractionated P1 and P2 cells are of high purity. Three 
independent preparations of P1 and P2 subpopulations were performed and the results 
are summarised in Figure 3.9. The expression levels of these markers are expressed as 
52 
 
ratios to those of control sorted cells and plotted on log scale. Our results revealed that 
the P2 subpopulation expressed significantly higher levels of embryonic stem cell 
markers Oct4 and Nanog than the P1 subpopulation (Figure 3.9). Furthermore, P2 was 
strongly enriched for Lgr5 to 100-fold. Lgr5 is a G protein-coupled receptor that 
marks a newly discovered stem cell population in the intestinal crypt and pyloric 
gastric glands (Barker et al., 2007; Barker et al., 2010) (Figure 3.9) . P2 cells also 
expressed elevated levels of Sox9, which is reported to co-localise with Lgr5 in 
gastrointestinal stem cells (Barker et al., 2010; Van der Flier et al., 2009) (Figure 3.9). 
Taken together, these data indicate that the P2 subpopulation enriches for stem cell-
related genes, particularly Lgr5.  
 
Figure 3.9. Gene expression profiling of P1 and P2 subpopulations. Left panel: Cells were sorted into 
P1 and P2 gates based on Hoechst 33342 staining for qRT-PCR. In this experiment, a small gate for P1 
was applied to capture the highest dye effluxing-P1 cells. Right panel: Expression levels of embryonic 
and gastrointestinal stem cell makers are presented relative to those of control sorted cells that included 
the total population in the FACS plot. Three separate experiments were carried out and each dot on the 
plot represents a single experiment. Student’s t-tests were performed on P1 and P2 values for various 
genes and the corresponding p-values are shown (single and double asterisks denote p-value <0.05 







3.2.6 P2 cells display greater sphere-forming capacity than P1 cells 
To assess the functional significance of elevated expression of stem cell-
associated transcripts in the P2 subpopulation, in vitro sphere assay was performed to 
evaluate stem cell-like activity. Isolated P1, P2, control sorted and unsorted cells from 
the GIF-14 line were cultured in suspension in serum-free medium supplemented with 
growth factors. As sphere-forming assay measures stem cell-like activity at the single 
cell level, it is critical to seed cells at clonogenic density and keep them apart to yield 
accurate quantification of sphere-initiation. To reduce aggregation of cells, varying 
amount of methylcellulose was added in the sphere medium in different experiments. 
Under this culturing condition, P2 cells consistently displayed 5-fold greater sphere-
forming capacities than P1 cells, revealing that they possessed increased 
stem/progenitor properties (Figure 3.10A). P2-derived spheres could be maintained 
for an extended period without obvious signs of differentiation. Moreover, in a 
preliminary experiment, these spheres could be serially passaged to generate 
secondary spheres readily, which is indicative of self-renewal activity (Figure 3.10B). 
In comparison, P1 cells were both less efficient in forming long-lived primary spheres 















Figure 3.10. Relative sphere-initiating efficiency of P1 and P2 subpopulations. (A) FACS-isolated P1 
and P2 cells were compared to control sorted (all cells on the FACS plot) and unsorted cells for sphere-
forming potential. Cells were cultured in serum-free medium supplemented with various growth factors 
as stated in Section 2.9 and 0.1% of methylcellose was added to the culture media to reduce the 
formation of cell aggregates. The graph represents the number of spheres ≥300µm in size generated 
from 5000 cells after 30 days of culture (means ± SEM, n=5). Double asterisks denotes p-value <0.01. 
Phase contrast images of spheres are shown. Scale bars, 300µm. (B) Primary spheres were dissociated 
and replated to generate secondary spheres following the procedures described in Section 2.9. The 
graph represents the number of secondary spheres formed from each cell population after 20 days of 





3.2.7 Wnt3a activates Lgr5 expression and promotes sphere formation 
It was reported that the gastrointestinal stem cell marker, Lgr5 is a target of 
the canonical Wnt pathway in the intestinal epithelium (Barker et al., 2007). More 
recently, Lgr5 has been shown to amplify Wnt signaling through its association with 
R-spondin proteins (de Lau et al., 2011). As the P2 subpopulation in GIF-14 cell line 
was found to enrich for Lgr5, activation of Lgr5 by the Wnt pathway was hence tested 
in this cell model. To stimulate the canonical Wnt signaling, FACS-isolated P1, P2 
and unsorted parental GIF-14 cells were either treated with Control- or Wnt3a-
conditioned medium (Cm) for 15h prior to qRT-PCR analysis. The results revealed 
that Lgr5 mRNA levels were greatly activated by Wnt3a-Cm in GIF-14 cells (Figure 
3.11). 
 
Figure 3.11. Changes in Lgr5 mRNA expression upon Wnt3a stimulation. FACS-isolated P1, P2 and 
GIF-14 unsorted cells were treated with Control- or Wnt3a-Cm in 1:3 ratio to the culture medium for 15h 
and Lgr5 mRNA levels were ascertained, normalised against those of Gapdh. Data are presented 




To ascertain whether Wnt3a promotes sphere formation as reflected in its 
induction of Lgr5, sphere-forming assay was carried out to examine the efficiency of 
sphere formation in GIF-14 cells in the presence of Wnt3a-Cm. To optimise the 
conditions for sphere formation using conditioned media, Control- and Wnt3a-Cm 
was diluted with sphere medium at various ratios of 1:20, 1:10 and 1:3. Treatment 
with Wnt3a-Cm led to a 2-fold increase in sphere-initiation across all dilution factors 
compared to Control-Cm (Figure 3.12A). As conditioned medium contained low 
levels of serum, which promoted the formation of cell aggregates, the amount of 
conditioned medium was kept minimal while maintaining good Wnt3a-reponsiveness. 
Thus, a dilution factor of 1:10 was chosen for the subsequent experiment. Under this 
condition, Wnt3-Cm treatment consistently resulted in increased sphere formation by 
2-fold relative to Control-Cm (Figure 3.12B).  
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Figure 3.12. The effects of Wnt3a-Cm treatment on sphere formation. (A) Sphere-forming assay was set 
up at various dilutions 1: 20, 1:10 and 1:3 of Control- and Wnt3a-Cm with sphere medium using GIF-14 
parental cells. Spheres ≥75µm in size were counted after 9 days of culturing and 0.5% of 
methylcellulose was used to keep the cells apart as low amount of serum in the conditioned media 
caused cell aggregation. (B) The above experiment was repeated with 1:10 Control- and Wnt3a-Cm 
dilution and spheres ≥100µm in size were scored after 11 days. The number of spheres are presented in 





To understand the basis of the tumorigenic nature of immortalised murine 
Runx3-/-.p53-/- gastric epithelial cell lines, we set out a thorough characterisation of a 
Runx3-/-.p53-/- line, GIF-14, with the aim of identifying and studying the tumorigenic 
population. Through a combination of Hoechst 33342 and cell surface marker staining, 
we identified a low dye-effluxing P2 subpopulation within GIF-14 that was marked 
by EpCAMlowCD133- antigen profile. P2 cells were found to display significantly 
greater tumor-initiating activity when transplanted in nude mice. 
In our study, the Hoechst 33342 staining technique was a valuable tool for 
isolating the subpopulations in the GIF-14 cell line. Although fractionation by FACS 
based on Hoechst 33342 profile is typically laborious and slow, it ensures that the 
enriched P1 and P2 subpopulations are of high purity. This is critical for comparing 
the relative tumorigenicity of these subpopulations in functional assays. It should be 
noted that the dye uptake kinetics are highly dynamic and the Hoechst 33342 profile 
of a mixed population is a function of arbitrary settings on the flow cytometer 
(Ibrahim et al., 2007; Wu and Alman, 2008). Although the P1 subpopulation shares 
the common attributes of low Hoechst 33342 fluorescence and verapamil sensitivity, 
it is not considered analogous to a true SP. Despite being present in many cancer cell 
lines, the physiological relevance of the SP during in vitro culture remains a topic of 
contention. It is known that the function of normal stem cells is highly dependent on 
contextual signals from the surrounding niche, which also seems true for TICs (Clarke 
et al., 2006). The high dye efflux may improve the survival of TICs in adverse 
microenvironment and confer drug resistance. However, the immortalised GIF-14 cell 
line maintained in in vitro culturing conditions may possess different Hoechst 33342 
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efflux properties compared to cells residing in their tissue niche. Indeed, the low dye 
effluxing-subpopulation, P2 correlates with tumorigenicity in GIF-14 cells. 
In view of these drawbacks in Hoechst 33342 staining, expression of cell 
surface markers in the subpopulations of GIF-14 would provide useful information 
about their differentiation states. The tumorigenic P2 fraction was depleted for CD133, 
EpCAM and CD49f cell surface markers, suggesting a link between loss of epithelial 
phenotype and tumorigenicty (Table 3.2). This relationship is also demonstrated in the 
marked reduction in the expression of Claudin-1, which is a critical component of the 
epithelial tight junction in tumorigenic Runx3-/-.p53-/- GIF cell lines compared to 
Runx3+/+.p53-/- cells (Chang et al., 2010). In addition, Runx3-/-.p53-/- GIF cell lines 
were prone to trans-differentiation into intestinal-like cells, indicating that they do not 
retain strong epithelial cell identity (Fukamachi et al., 2004; Fukamachi et al., 2008). 
Allograft transplantation assays in nude mice revealed that the P2 
subpopulation was significantly more tumorigenic than the P1 counterpart (Figures 
3.5 and 3.7). It has been reported that complete tissue disruption during the retrieval 
of TICs from their living niche would select for cells that are more independent of 
their niche or better equipped for survival in mice (Vermeulen et al., 2008). Thus, the 
increased tumorigenicity observed in the P2 subpopulation may be attributed to their 
greater adaptability and resistance to apoptosis in the graft niche. As P2 cells are 
unable to efflux Hoechst 33342, they retained high levels of the dye which can be 
cytotoxic. The fact that the P2 subpopulation would still initiate tumours more readily 
strongly suggests that P2 cells have a survival advantage over P1 cells. Alternatively, 
the tissue microenvironments into which the cells were transplanted might have 
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preferentially supported the growth of P2 cells by providing the necessary growth 
factors and nutrients. 
In addition to the significant differences between P1 and P2, variations in the 
ability to form tumours by the P1 subpopulation from two independent 
transplantations were observed (Figures 3.5 and 3.7). These could be explained by the 
differences in the immune system and tumour immunity of the nude mice used in the 
two experiments. Differences in the age of mice and number of cells transplanted in 
these experiments could trigger varied immune responses. nude mice are deficient in 
T and B cells, but they contain natural killer cells that constitute a major part of innate 
immunity against foreign cells or tumour growth (Flanagan, 1966). Despite the 
murine origin of transplanted cell populations, immune response against these cells 
could still be mounted. Therefore, to eliminate the contribution of immune cells, more 
immune-comprised NOG (NOD/Shi-scid/IL-2Rγnull ) mice which lack T, B, natural 
killer and antigen presenting cells could be used to improve engraftment of foreign 
cells (Ito et al., 2002).  
The relationship between tumour-initiation activity and stem/progenitor 
phenotype has been established in many contexts. In the GIF-14 cell line, the P2 
tumorigenic subpopulation was highly enriched for stem cell-related markers, 
especially the gastrointestinal stem cell marker Lgr5 as revealed by gene expression 
profiling. Functionally, these Lgr5-expressing cells form long-lived spheres that could 
be serially passaged in serum-free cultures more readily than other cells within GIF-
14. Thus, the P2 subpopulation displayed stem/progenitor features. Our results 
support the notion that TICs display stem/progenitor characteristics, suggesting that 
signaling pathways regulating self-renewal may be conserved among TICs. Although 
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these pathways are tightly controlled in normal stem cells, they may be constitutively 
activated or mis-regulated in TICs, leading to tumorigenesis (Beachy et al., 2004). For 
instance, the canonical Wnt pathway is well known to regulate the self-renewal of 
crypt stem/progenitor cells in intestinal epithelium (Korinek et al, 1998). Aberrant 
activation of Wnt signaling is heavily involved in the carcinogenesis of 
gastrointestinal neoplasia (Clevers, 2006). In GIF-14 cells, treatment with Wnt3a-Cm 
which mimicked constitutive stimulation of Wnt signaling resulted in increased 
stem/progenitor activity, as reflected from the robust induction of Lgr5 and greater 
sphere-formation (Figures 3.11 and 3.12).  
The correlation between Lgr5, a target of the Wnt pathway with 
stem/progenitor characteristics and tumorigenicity has implications in the etiology of 
gastric cancer. During cancer development, abnormal activation of growth factor 
signaling such as the canonical Wnt pathway through genetic or/and epigenetic 
alterations may activate Lgr5 and impart stem/progenitor properties. These Lgr5-
expressing cells may become targets for oncogenic insults, leading to the generation 
of TICs that drives tumour growth. This hypothesis is supported by the recent report 
that Lgr5-positive stem cells are the cells-of-origin of intestinal adenomas in mouse 
model (Barker et al., 2009). Therefore, it is probable that Lgr5-expressing P2 
subpopulation within the precancerous Runx3-/-.p53-/- GIF-14 cell line represents 
precursors of these TICs in full-blown cancer. It has been reported that Lgr5 
expression is exclusively restricted to the crypt base columnar stem cells in the 
intestines and is quickly silenced in their transit-amplifying daughter cells (Van der 
Flier et al., 2009).  Given its tight regulation in vivo, it is remarkable that a 
subpopulation of an immortalised cell line is enriched for Lgr5. The cause for the 
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appearance of the tumorigenic, less epithelial-like and Lgr5-positive P2 subpopulation 




CHAPTER 4:  
Spontaneous EMT gives rise to the tumorigenic and stem 





















4.1.1 Properties of epithelial cells and mesenchymal cells 
The epithelium is an important tissue with unique properties and it lines most 
of the internal organs, covering the internal and external surfaces of the body. The 
epithelia are composed of epithelial cells that are tightly bound together in sheets and 
form barriers which protect the body from the external environment (Kolega, 1985). 
The epithelial cells are joined together by specialised membrane structures such as 
adherens junctions, tight junctions, gap junctions and desmosomes, organised as a 
lateral belt. These cells possess apical-basal polarity as reflected in the presence of 
distinct membrane proteins and outer-leaflet on the apical versus basolateral plasma 
membrane domains. The epithelial cells are typically polygonal in shape and their 
movements are restricted within the epithelial layer (Fristrom, 1988). In our study, the 
GIF cell lines are established from epithelial cells of the mouse stomach, which 
consist of simple columnar epithelial cells that are elongated and columnar.  
Distinct from epithelial cells, mesenchymal cells are found most abundantly in 
the connective tissue and are vastly different in their properties. Unlike epithelial cells, 
mesenchymal cells do not form organised sheets, and consequently lack the apical-
basal polarity as their epithelial counterparts, which are arrayed according to proper 
cell-cell junctions and actin cytoskeleton arrangement. Owing to these properties and 
their weaker cell-cell adhesion, mesenchymal cells possess migratory capabilities, 
often making transient contacts with their neighbours (Schock and Perrimon, 2002). 
In culture, mesenchymal cells adopt a spindle-shaped morphology and are highly 
motile, whereas polygonal-shaped epithelial cells grow as clusters of cells that 
maintain complete cell-cell adhesion with each other (Thiery and Sleeman, 2006). 
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4.1.2 Epithelial-Mesenchymal Transition 
The epithelial-mesenchymal transition (EMT) refers to a complex cellular and 
molecular programme through which epithelial cells temporarily lose their 
characteristics, such as cell-cell adhesion and apical-basal polarity, and take on the 
properties of mesenchymal cells such as cell motility. This process has long been 
recognised as a fundamental event in morphogenesis and organogenesis during 
embryonic development in vertebrates and invertebrates (Hay, 1968). The epithelial 
cells that are converted to mesenchymal cells migrate to distant sites where they 
undergo a reverse process, termed mesenchymal-epithelial transition (MET) to give 
rise to internal organs (Nieto, 2011). Several rounds of EMTs and METs are 
necessary for the formation of body plan and differentiation of multiple tissues and 
organs (Baum et al., 2008). EMT first occurs during gastrulation in which epiblast 
cells break away from the basement membrane to delaminate from the primitive 
streak to form the mesoderm germ layer (Shook and Keller, 2003). At later stage of 
embryogenesis, neural crest cells arising from the dorsal part of the neural tube 
undergo EMT and migrate to contribute to the formation of various tissues, including 
neurons, bones, smooth muscles and melanocytes (Lee et al., 2006). Subsequently, 
secondary and tertiary cycles of EMTs and METs are also responsible for the 
development of other structures, particularly the somites, heart, secondary palate, 
reproductive tracts and placenta (Thiery et al., 2009).  Consistent with the importance 
of EMT in embryogenesis, mutations in genes driving EMT are often associated with 
congenital defects such as mesodermal malformation and neural crest emigration 
failure (Nieto et al., 1994; Carver et al., 2001).  
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The hallmarks of EMT are defined by the loss of cell-cell junctions, disruption 
of apical-basal polarity, changes in cell shape and the acquisition of cell motility 
(Thiery and Chopin 1999). These typically involve the dissolution of epithelial 
junctional structures consisting of adherens junction, tight junctions and desmosomes. 
Loss of E-cadherin, a major component of the adherens junction with concurrent 
upregulation of non-epithelial cadherins such N-cadherin has been regarded as a 
critical event of EMT (Llorens et al., 1998). Concurrently, constituents of the core 
polarity complexes such as Par, Crumbs and Scribble are often downregulated or 
reorganised (Moreno-Bueno et al., 2008). Concomitant with the loss of epithelial cell 
identity, epithelial cells gain mesenchymal features such as spindle-like morphology, 
increased cell motility and invasion (Thiery, 2002). These often involve concerted and 
dramatic changes in the cytoskeleton organisation and extracellular matrix (ECM) 
composition to allow cells to change shape and migrate. Typically, reorganisation of 
the actin cytoskeleton and increased production of cytoskeletal and ECM proteins 
such as vimentin and fibronectin occur which leads to the stimulation of the integrin 
signaling to facilitate cell migration and invasion (Xu et al., 2009).  
 
As EMT and MET are highly controlled and spatial-temporally regulated 
processes during embryonic development, they do not occur under usual 
circumstances. However, reactivation of the EMT trans-differentiation programme in 
adulthood has been implicated in the conversion of early stage tumours to invasive 
malignancies (Thiery, 2002). Increasing findings reveal that the acquisition of an 
EMT phenotype is critically linked to epithelial cancer progression and metastasis 
which allows tumour cells to disseminate from primary tumours to distant loci 
through intravasation into the blood circulation (Irie et al., 2005; Chaffer et al., 2006; 
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Aigner et al., 2007; Moustakas and Heldin, 2007). Subsequently, these metastatic 
tumour cells with mesenchymal phenotype are believed to undergo MET to form 
macroscopic metastases at secondary sites that resemble the primary tumours (Kong 
et al., 2011). Therefore, it appears that the regulatory programme that governs 
embryonic EMT is exploited by tumour cells to adopt metastatic traits during tumour 
progression (Thiery et al., 2009).  
 
4.1.3 Regulatory factors controlling EMT 
EMT is regulated by a complex network of transcriptional regulators under the 
control of mitogenic signals. During EMT, various extracellular cues including 
soluble growth factors and components of the ECM activate a genetic program that 
leads to pronounced cellular changes in epithelial cells (Boyer et al., 2000). Multiple 
growth factors and morphogens, such as transforming growth factor-β (TGF-β), Wnt, 
fibroblast growth factor (FGF), hepatocyte growth factor (HGF), epidermal growth 
factor (EGF), Notch and sonic hedgehog proteins are capable of inducing an EMT 
(Thiery and Sleeman et al., 2006). The gene regulatory networks governing EMT 
during embryonic development have been well established in sea urchin and 
Drosophila, whereas those operating in the vertebrates are far from complete (Thiery, 
2009). The key transcription factors involved in the regulatory loops include Snail, 
Twist, Zeb, Foxc, Goosecoid, Sox, Eomesodermin, Mesps and others, of which the 
Snail, Twist and Zeb families are best characterised in the mammalian system (Polyak 
and Weinberg, 2009; Thiery, 2009). Recently, a non-histone chromatin binding factor, 
the high mobility group a2 (Hmga2), has been proposed to be a potential master 
regulator of EMT, whereby ectopic expression of HMGA2 activated the transcription 
of Snai1, Snai2 and Twist (Thuault et al., 2006). The induction of these transcription 
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factors in response to extracellular signals leads to the activation or repression of 
several sets of genes that influence cell morphology and behaviour. These molecular 
targets consist of epithelial/polarity genes such as E-cadherin, β-catenin, zonula 
occludins (ZO), claudins, desmoplakin and Crumbs3, as well as mesenchyaml genes 
including fibronectin, vimentin, N-cadherin and matrix metalloproteases (MMPs) 
(Batlle et al., 2000; Ikenouchi et al., 2003; Yang et al., 2004; Vandewalle et al., 2005; 
Bindels et al., 2006; Shirakihara et al., 2007; Whiteman et al., 2008).  
 
4.1.4 TGF-β and Wnt signaling pathways are important regulators of EMT 
The TGF-β pathway is an important regulator of cellular processes such as cell 
proliferation, apoptosis and differentiation in the gastrointestinal tract (Derynck et al., 
1997). It is regarded as a tumour suppressor pathway in this context as inactivation of 
the components of the TGF-β signaling cascade is prevalent in gastrointestinal 
cancers (Park et al., 1994; Markowitz et al., 1995; Howe et al., 1998). The TGF-β 
signaling cascade has been well-delineated in which TGF-β signals through a 
heterodimeric complex of type I and type II trans-membrane receptors. Upon ligand 
binding to type II receptors, Smad2 and Smad3 are activated via phosphorylation by 
type I receptor kinases and form heterotrimeric complexes with Smad4. These 
complexes translocate into the nucleus and regulate the transcription of a variety of 
genes in collaboration with specific transcription factors and coactivators or 
corepressors (Massague et al., 2006). 
Members of the TGF-β family of cytokines are regarded as major inducers of 
EMT during embryogenesis. This is clearly demonstrated in the multiple 
developmental defects in the heart and palatal fusion in TGF-β-null embryos due to a 
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lack of EMT (Pelton et al., 1990; Dickson et al., 1995; Sanford et al., 1997). Due to 
its diverse functions in various tissues, the role of TGF-β in carcinogenesis is 
distinctively pleiotropic. Although TGF-β acts as tumour suppressor through the 
induction of growth arrest and apoptosis at the early stage of cancer, surprisingly it 
also acts as a major driver of metastasis during cancer progression by inducing EMT 
(Heldin et al., 2009; Massague, 2008). For instance, constitutive activation of TGF-β1 
in transgenic mice led to the development of invasive spindle cell carcinomas from 
benign skin tumours (Cui et al., 1996). Furthermore, cancer cells often produce 
autocrine TGF-β to activate EMT, which enhances survival and invasion of migratory 
cancer cells (Derynck et al., 2001).  
The canonical Wnt signaling pathway plays a central role in the development 
and regeneration of gastrointestinal tract, and its dysregulation is one of the best-
characterised causes of gastrointestinal neoplasia (Clevers, 2006). The association 
between Wnt and EMT has been established during embryogenesis in which Wnt is a 
necessary component to drive EMT in neural crest formation and somitogenesis 
(Garcia-Castro and Bronner-Fraser, 1997; Galceran et al., 2004). Wnt proteins 
regulate EMT through the control of β-catenin-mediated transcriptional activity. β-
catenin plays dual roles in EMT: it enhances cell-cell adhesion when associated with 
the E-cadherin complex in adherens junctions (Ozawa et al., 1989), it also functions 
as a transcription coactivator upon entry into the nucleus when Wnt pathway is 
activated (Behrens et al., 1998). Consistent with the key roles that EMT and an 
activated Wnt pathway play in cancer progression, the translocation of β-catenin from 
cell membrane to nucleus is often observed at the invasive front of the primary 
carcinomas in metastatic human cancers (Brabletz et al., 2001).   
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4.1.5 EMT promotes the formation of “cancer stem cells” 
Apart from its better studied involvement in advanced cancer, recent evidence 
suggests that EMT may have a role in tumour initiation by promoting the genesis of 
“cancer stem cells”. Two independent groups have demonstrated that mammary 
epithelial cells undergoing EMT gained stem cell-like characteristics (Mani et al., 
2008; Morel et al., 2008). Immortalised human mammary epithelial cells that were 
induced to undergo EMT upon the overexpression of Snai1 or Twist or TGF-β1 
treatment were capable of forming mammospheres in vitro, indicating that they 
display properties of stem cells (Mani et al., 2008). In a separate study, the 
constitutive activation of EMT in Ras-transformed mammary epithelial cells led to a 
significant increase in the number of cancer stem cells, marked by CD44highCD24low 
antigen profile (Morel et al., 2008). These data indicate that the aberrant activation of 
an EMT induces a genetic reprogramming in epithelial cells which enables them to 
become phenotypically plastic. As a result, epithelial cells acquire stem cell 
characteristics, mesenchymal features, resistance to apoptosis and eventually become 
tumorigenic (Polyak and Weinberg, 2009). 
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4.1.6 Experimental approach 
In the Runx3-/- GIF-14 cell line, the P2 subpopulation was found to be depleted 
for epithelial-specific surface antigens CD133, EpCAM and CD49f, suggesting that 
P2 cells display reduced epithelial phenotype. As the P2 subpopulation was shown to 
be tumorigenic, the relationship between a loss of epithelial characteristics and the 
tumorigenicity in the GIF-14 cell line will be investigated in the context of EMT. To 
achieve this, the following experimental approaches are taken: (1) measuring the gene 
expression of specific markers by quantitative RT-PCR, and their sub-cellular 
distribution by immuno-fluorescent staining; and (2) live monitoring of cell behaviour 
by time-lapse imaging. In the former approach, gene expression profiling of epithelial 
markers E-cadherin and EpCAM, EMT-inducing transcription factors Snai1, Snai2 
and Twist and mesenchymal markers N-cadherin, Vimentin, Fibronectin will be 
performed in GIF-14 subpopulations. Secondly, immuno-fluroscent staining coupled 
with confocal microscopy will be employed to study the distribution of epithelial- and 
mesenchymal-related proteins. This technique is widely practiced as high resolution 
three-dimensional images displaying spatial localisation of proteins using specific 
fluorescent dyes can be generated (Wright et al., 1993). To track the behaviour of 
cells in terms of their cell morphology and migration real-time, live cell imaging 
techniques such as time-lapse imaging will be performed. Time-lapse imaging is 
particular useful for sequence-capturing of dynamic cellular events over a long period 
of time (Jang et al., 2011). Finally, the effects of various EMT-inducing growth 
factors, in particular TGF-β and Wnt, on gene expression and cell biology of GIF-14 




4.2.1 The P2 subpopulation displays mesenchymal-like characteristics 
P1 and P2 subpopulations displayed distinct cell morphology when cultured 
on plastic culture dish and glass cover slips. Figure 4.1 shows the morphologies of 
FACS-purified P1 and P2 cells grown on plastic culture dish at sub-confluent 
densities. P1 cells resembled typical epithelial cells with polygonal shapes. In contrast, 
P2 cells displayed features similar to mesenchymal cells, such as elongated and 
spindle-like morphologies (Figure 4.1). Although both subpopulations were seeded at 
the same cell density, the P1 subpopulation formed cell clusters more readily than the 
P2 subpopulation, suggesting that the P1 cells have relatively stronger cell-cell 
adhesion (Figure 4.1).  
 
Figure 4.1. P1 and P2 cells in the GIF-14 cell line showed distinct differences in cell morphology. P1 
and P2 cells were fractionated by FACS and they were expanded in vitro. Images of these cells at sub-






To confirm the above observations, time-lapse imaging was carried out to 
monitor the growth of P1 and P2 colonies. Freshly FACS-fractionated P1 and P2 cells 
were seeded at clonogenic densities on glass cover slips for the formation of single 
cell-derived colonies. The glass cover slips were transferred into a Sykes Moore 
chamber and mounted on a Nikon Ti Eclipse microscope through which images were 
captured at 3 min intervals. The progressive, time-lapse images of a representative 
colony from each subpopulation at indicated times of imaging are presented in Figure 
4.2. P1 colonies took on a compact appearance and grew slowly in a cohesive manner, 
where neighboring cells were in constant contact with each other, thus displaying 
characteristics of epithelial cells (Figure 4.2). This observation was conserved in all 
P1 colonies monitored over the course of 18h. In striking contrast, cells within P2 
colonies were disorganised in their arrangement and expanded rapidly with constant 
delamination and outward migration. These properties were particularly pronounced 
at the boundaries of P2 colonies (Figure 4.2). The dynamics and high motility of the 
P2 cells revealed by time-lapse imaging suggest that the P2 cells may possess weaker 




Figure 4.2. P1 and P2 colonies displayed markedly different morphology and migration. Time-lapse 
imaging of single-cell derived P1 and P2 colonies was performed in which images were captured by 
differential interference contrast (DIC) microscopy at 3min intervals over a period of 18h. Images of 




To further assess the mesenchymal nature of the P2 subpopulation, gene 
expression profiling experiments were performed in which the expression of well-
established EMT- and mesenchymal-associated markers in P1 and P2 subpopulations 
were measured by quantitative RT-PCR. The gating strategy employed for the 
fractionation of P1 and P2 subpopulations by FACS is similar to that in Figure 3.9 in 
which P1 cells with the greatest dye efflux was captured by setting a small and 
selective gate. In total, three independent fractionations of GIF-14 cells were 
performed and the expression levels of each marker gene were calculated as ratios to 
those of the control samples (Figure 4.3). In all the experiments, mesenchymal 
markers such as Fibronectin (Fn1) were significantly elevated in the P2 
subpopulation (Figure 4.3). Furthermore, the P2 subpopulation expressed markedly 
higher levels of key EMT-inducing transcription factors, Snai1, Snai2 and Twist 
compared to the P1 subpopulation (Figure 4.3). Lastly, P2 cells had reduced 
expression of the epithelial cell marker, EpCAM, and this is in agreement with the 
lower EpCAM protein levels in these cells as determined by surface antigen staining 
and flow cytometry in Table 3.2. Taken together, our data indicate that the P2 
subpopulation has reduced epithelial characteristics and concurrently displays 
morphological and molecular properties of mesenchymal cells.   
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Figure 4.3. Expression levels of epithelial-, EMT- and mesenchymal-related markers in P1 and P2 cells. 
Left panel: Cells were fractionated based on Hoechst 33342 staining into P1 and P2 populations for 
qRT-PCR. A small gate was set to collect P1 cells with the greatest dye efflux potential. Right panel: 
Expression levels of epithelial-, EMT-, and mesenchymal-associated genes relative to those of control 
sorted cells (total population in the FACS plot). Data presented are a compilation of three independent 
experiments and each dot on the plot represents the read-out of a single experiment. Student’s t-tests 
were performed on P1 and P2 values. Double asterisks denotes p-value <0.01.   
 
4.2.2 TGF-β1 induces EMT- and mesenchymal-related genes in GIF-14 cells 
To induce EMT experimentally in the GIF-14 cell line, parental GIF-14 cells 
were treated with human recombinant TGF-β1 ligand for 24h and 48h. Changes in 
EMT- and mesenchymal-related markers that were enriched in the P2 subpopulation 
were determined by qRT-PCR. These treatments resulted in robust induction of 
EMT/mesenchymal-associated genes (Figure 4.4). Induction was most prominently 
observed in Snai1 at 24h post-treatment. In contrast, N-cad, Fn1 and Snai2 were 
strongly induced at 48h post-treatment (Figure 4.4). These observations suggest that 
the activation of Snai1 by TGF-β1 is probably a primary event that leads to the 
secondary induction of its target genes, such as N-cad and Fn1. Collectively, the 
above results suggest that an EMT has been induced by TGF-β1 in GIF-14 cells. 
Unexpectedly, treatment of TGF-β1 also caused 5-fold induction of Lgr5 transcript in 
GIF-14 cells at 48h post-treatment (Figure 4.4). As Lgr5 is a specific gastrointestinal 
stem cell marker, this finding is consistent with the notion that EMT promotes the 
acquisition of stem cell-like properties in epithelial cells.  
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Figure 4.4. Changes in the expression of EMT- and mesenchymal-related genes in response to TGF-β1 
treatment. Parental GIF-14 cells were treated with 2.5ng/ml of TGF-β1 for 24 or 48h and changes in the 
expression of epithelial-, EMT- and mesenchymal-related genes were determined by qRT-PCR. The 
values of each gene were normalised against those of Gapdh and expressed relative to the untreated 
controls. The data from three independent experiments were compiled (means ± SEM, n=3). Single and 




4.2.3 TGF-β1 and Wnt3a promotes the expansion of the P2 subpopulation 
The strong resemblance between the P2 subpopulation and GIF-14 cells that 
have undergone TGF-β1-induced EMT suggests that P2 cells are the product of EMT. 
To demonstrate this, Hoechst 33342 staining was performed on GIF-14 cells treated 
with TGF-β1 at various time points across a 10-day period. To account for changes 
due to culture conditions, untreated cells were traced for the same period of time. 
Compared to the untreated cells, three days of TGF-β1 treatment resulted in an 
expansion of the P2 subpopulation from 4.8% to 10.1%. This was concomitant with 
shrinkage of the P1 subpopulation from 51.0% to 22.3% (Figure 4.5A). This trend 
was persistent and further enhanced over 10 days of TGF-β1 treatment period (Figure 
4.5A). In this analysis, a small P1 gate was marked to highlight a receding of the “tip” 
of P1, which indicated a loss of dye efflux over time.  It is worth noting that the same 
conclusion could be drawn when a larger gate was used. 
As P1 and P2 cells could further be distinguished by their differential EpCAM 
and CD133 expression, changes in these markers were also measured by flow 
cytometry, and presented as a percentage of the total cell population. Consistent with 
the enlargement of P2 subpopulation, the fraction of the P2-associated 
EpCAMlowCD133- cells increased from 51% to 84% after 10 days of TGF-β1 
treatment (Figure 4.5B). This was accompanied by a decrease in the percentage of the 
P1-associated EpCAMhighCD133+ cells from 49% to 16% (Figure 4.5B). Together, 
these data provide strong evidence that TGF-β1 treatment promotes an expansion of 









Figure 4.5. The effects of TGF-β1 treatment on Hoechst 33342 and cell surface marker staining profiles. 
GIF-14 cells were treated with 2.5ng/ml of TGF-β1 for a period of 10 days. Co-staining of Hoechst 
33342 together with CD133 and EpCAM was performed at indicated time points and the cells were 
analysed on the flow cytometer. Changes in Hoechst 33342 staining profile were presented on the 
FACS plots (A) while the percentages of EpCAMhighCD133+ and EpCAMlowCD133- cells relative to their 
combined values were shown in (B). Student’s t-test was performed for day10 after TGF-β1 treatment 




The above observations prompted us to test the effects of Wnt3a, which is 
another well known inducer of EMT. To activate the canonical Wnt signaling, 
parental GIF-14 cells were treated with Wnt3a-conditioned medium (Wnt3a-Cm) or 
control-Cm over a period of 10 days. To determine the effects of Wnt, changes in 
EpCAMhighCD133+ and EpCAMlowCD133- fractions were ascertained by flow 
cytometry over the course of the treatment. Relative to control-Cm, Wnt3a-Cm 
resulted in increased EpCAMlowCD133- cells from 43.1% to 56.3% after 3 days of 
treatment. Concomitantly, slight decrease in EpCAMhighCD133+ cells was observed in 
Wnt3a-Cm treated cells (Figure 4.6). This effect was gradually enhanced with 
prolonged Wnt3a-Cm treatment (Figure 4.6). However, it was noted that control-Cm 
caused a milder but similar effect to that of Wnt3a-Cm, indicating that conditioned 
media may contain certain growth factors which would induce EMT (Figure 4.6). 
 
Figure 4.6. The effects of Wnt3a-Cm treatment on CD133/EpCAM marker profile. GIF-14 cells were 
subjected to CD133 and EpCAM staining at the indicated time points, following a period of 10 days of 
treatment with Control or Wnt3a-Cm (1:3 dilution with culture medium). Changes in CD133/EpCAM 




4.2.4 TGF-β1 causes a direct transition of  P1 to P2 phenotype 
The preliminary observation that TGF-β1 treatment leads to an expansion of 
the P2 subpopulation with simultaneous decrease in P1 subpopulation could be either 
due to: 1) TGF-β1 induces a direct transition of P1 to P2 phenotype or 2) a negative 
selection against P1 cells by TGF-β1. To exclude the latter possibility, time-lapse 
microscopy was employed to study changes in single-cell derived P1 colonies 
following TGF-β1 treatment. Two independent imaging experiments were conducted 
in which P1 colonies were cultured on plastic plates and glass cover slips for phase 
contrast (Figure 4.7A) and differential interference contrast (DIC) imaging (Figure 
4.7B), respectively. The colonies were allowed to adapt to the environment in the 
culture chamber prior to TGF-β1 treatment for 67h. Images of representative colonies 
at indicated time points are shown in Figures 4.7A and 4.7B. Untreated colonies were 
imaged simultaneous in a separate well or chamber to account for the effects of 
culturing conditions on the behaviour of cells. 
In these experiments, TGF-β1 treatment of P1 colonies did not trigger 
apoptosis; rather it resulted in a marked gain in mesenchymal-like phenotype (Figure 
4.7A). As the treatment progressed, TGF-β1-treated cells took on a stretched and 
spindle-like morphology. Moreover, cells became increasingly detached and motile at 
the periphery of the colonies (Figure 4.7A). These changes were in striking contrast to 
the untreated control colonies which displayed epithelial properties. This phenomenon 
was clearly observed in two separate imaging experiment using different microscopy 
and culture substrata, namely plastic/phase-contrast and glass slip/DIC imaging 
(Figure 4.7B). Importantly, the resultant phenotype of P1 colonies following TGF-β1 
treatment closely resembled that of P2-derived colonies (Figure 4.7 & 4.2). Therefore, 
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these data provide strong evidence that the expansion of P2 subpopulation in GIF-14 
cells upon TGF-β1 treatment described in Section 4.2.3 is due to a direct transition of 
P1 cells to cells bearing P2 phenotypes. 
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Figure 4.7A. Morphological changes in P1 colonies induced by TGF-β1. Time-lapse microscopy of 
single-cell derived P1 colonies treated with 2.5ng/ml of TGF-β1 was set up according the descriptions in 
Section 2.10. Phase contrast images of control and TGF-β1 treated P1 colonies cultured on low 
evaporation 6-well plastic plates were taken concurrently for 67h at 5min intervals. Images of the 





Figure 4.7B. Morphological changes in P1 colonies induced by TGF-β1. Time-lapse microscopy of 
single-cell derived P1 colonies treated with 1.25ng/ml of TGF-β1 was set up as described in Section 
2.10. DIC images of control and TGF-β1 treated colonies grown on glass cover slips were captured in 
separate Sykes Moore chambers for 84h at 5min intervals. Images of the representative colonies at the 




4.2.5 TGF-β1 causes major sub-cellular changes in GIF-14 cells 
The sub-cellular changes in cells undergoing EMT have been extensively 
studied. To provide conclusive evidence that TGF-β induces EMT in GIF-14 P1 
colonies, immuno-fluorescent staining of cell-cell adhesion proteins and 
mesenchymal markers were performed. In this study, single-cell derived untreated or 
TGF-β1 treated P1 as well as P2 colonies were stained for desmoplakin, F-actin and 
β-catenin. High and low magnifications of confocal images of representative colonies 
were captured (Figure 4.8A and 4.8B). Desmoplakin is an essential component of the 
desmosomes that is a major feature of epithelial cells, as described in Section 4.1.3. In 
untreated P1 colonies, desmoplakin staining was prominent at intercellular boundaries 
where it appeared as punctate foci consistent with the presence of desmosomes. After 
48h of TGF-β1 treatment, a pronounced redistribution of desmoplakin from the 
plasma membrane to the cytoplasm and nuclei was observed, indicating a disassembly 
of the desmosomes (Figures 4.8A and 4.8B).  
F-actin filaments are important constituents of the cytoskeleton structures 
required for the maintenance of cell-cell junctions and cell shape. In untreated P1 
colonies, F-actin was largely localised in close proximity to the cell membrane. TGF-
β1 treatment of P1 cells resulted in a striking reorganisation of F-actin filaments in the 
form of stress fibres (Figures 4.8A and 4.8B). This is consistent with the observed 
increase in cell motility as shown in Figure 4.7. As stress fibres are part of the focal 
adhesion complex formed when cells make stable connections to the substratum, they 
enable cells to extend their leading edge to attach to the substratum for movement 
(Doherty and McMahon, 2008). 
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The immuno-fluorescent staining of β-catenin revealed its predominant 
localisation at intercellular junctions in untreated P1 colonies. TGF-β1 treatment 
caused a loss of membranous β-catenin staining in P1 cells, indicating a disruption of 
the adherent junctions (Figures 4.8A and 4.8B). In addition, increased nuclear β-
catenin staining was observed in cells at the periphery of the colonies, suggesting an 
activated Wnt signaling (Figures 4.8A and 4.8B). Therefore, TGF-β1 treatment 
induced a change of cell-cell adhesion structures and increased cell motility in P1 
colonies. More importantly, the resultant phenotype induced in P1 colonies by TGF-
β1 resembled closely to those of P2-derived colonies (Figure 4.8A and 4.8B). This 
coincides with the adoption of P2-like cell morphology and motility by P1 colonies 
upon TGF-β1 treatment shown in Figure 4.7. Interestingly, a gradient of decreasing 
epithelial with concurrent increasing mesenchymal features from the centre towards 
the edge of single-cell derived P2 colonies was observed, reflecting an inherent state 


































































































































































































































































































































































































































































































































4.2.6 Autocrine TGF-β drives spontaneous EMT in the GIF-14 line 
The occurrence of a mesenchymal-like P2 subpopulation under normal 
culturing of GIF-14 cells suggests that these cells are undergoing spontaneous EMT. 
Therefore, the possibility that an autocrine and constitutively active TGF-β pathway 
which promotes and maintains the P2 subpopulation in steady state was investigated. 
In this study, a specific and potent TGF-β inhibitor, SB431542, abrogates TGF-β 
signaling by inhibiting the phosphorylation of Smad2 by type I TGF-β receptors 
(Inman et al., 2002) was used. Parental GIF-14 cells were pre-treated with TGF-β 
inhibitor for 15h prior to the addition of TGF-β1 ligand for another 48h. TGF-β 
activity was assessed by immuno-fluorescent staining of total and phosphorylated 
Smad2/3, the nuclear effectors of TGF-β signaling. Untreated GIF-14 cells showed 
cytoplasmic and nuclear staining of total Smad2/3, indicating that the TGF-β pathway 
is partially and constitutively active in GIF-14 cells (Figure 4.9). Treatment with 
TGF-β1 triggered nuclear translocation of cytoplasmic Smad2/3, yielding exclusive 
nuclear total Smad2/3 staining (Figure 4.9). Pre-treatment with SB431542 blocked the 
nuclear accumulation of total Smad2/3 in both untreated and TGF-β1 treated cells, 
demonstrating the inhibition of autocrine and exogenous TGF-β signaling (Figure 4.9). 
However, despite the clear redistribution of total Smad2/3, persistent localisation of 
phosphorylated Smad2/3 in the nucleus was observed though the canonical TGF-β 









































































































































































































































Phase contrast images were captured to evaluate the changes in cell 
morphology in response to SB431542. GIF-14 cells were pre-treated with SB431542 
for 15h before treatment with TGF-β1 for 24h. As described in Sections 4.2.4 and 
4.2.5, TGF-β1 treatment resulted in distinct morphological changes in GIF-14 cells 
and endowing them with mesenchymal features (Figures 4.7 and 4.8). Concordant 
with the nuclear exclusion of total Smad2/Smad3, treatment with SB431542 
effectively blocked the TGF-β1-induced morphological changes in GIF-14 (Figure 
4.10). Moreover, uninduced GIF-14 cells treated with SB431542 appeared epithelial-
like phenotype with greater compactness compared to resting GIF-14 cells (Figure 
4.10). These data suggest that a constitutively active TGF-β pathway promotes 
mesenchymal-like morphology in some GIF-14 cells and its blockade by SB431542 
would reverse these changes and promote epithelial cell phenotype. 
                 
 
Figure 4.10. Changes in the cell morphology of GIF-14 cells upon TGF-β inhibitor (SB431542) 
treatment. GIF-14 cells were pre-treated with 10µM of SB431542 for 15h prior to the addition of 2.5ng/ml 
of TGF-β1 for another 24h. Phase contrast pictures of these cells are shown. Scale bars, 50µm. 
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 To assess the effect of SB431542 on gene expression, qRT-PCR analyses were 
performed. Concordant with the observations described in Section 4.2.2, TGF-β1 
treatment resulted in elevated expression of Snai1, Snai2, Twist, Vim, Fn1 and Hmga2 
(Figure 4.11). Treatment with TGF-β inhibitor drastically reduced the basal and TGF-
β1-induced expression of these genes to a level below those of untreated controls 
(Figure 4.11).  
 
Figure 4.11. Changes in EMT- and mesenchymal-associated genes in GIF-14 cells upon TGF-β 
inhibitor (SB431542) treatment. GIF-14 cells were pre-treated with 10µM of TGF-β inhibitor for 15h prior 
to 24h of 2.5ng/ml TGF-β1 induction. EMT- and mesenchymal-related transcripts were ascertained by 
qRT-PCR. Expression levels were normalised against those of Gapdh and expressed relative to 




 Finally, to demonstrate whether TGF-β inhibitor promotes the P1 subpopulation, 
Hoechst 33342 staining was performed on GIF-14 cells treated with TGF-β inhibitor 
for an extended period. Treatment with TGF-β inhibitor for 3 days resulted in an 
increase in P1 subpopulation from 22.7% to 53.8%. This was accompanied by a 40% 
reduction in the P2 subpopulation from 9.91% to 6.48% (Figure 4.12). These effects 
sustained for 7 days of TGF-β inhibitor treatment (Figure 4.12). Therefore, these data 
suggest that TGF-β inhibitor drives cells towards the P1 phenotype.  
 
Figure 4.12. The effects of prolonged TGF-β inhibitor (SB431542) treatment on Hoechst 33342 staining 
profiles in GIF-14 cells. Parental GIF-14 cells were treated with 10µM of TGF-β inhibitor, SB431542 and 







4.2.7 EGF and HGF cooperate with TGF-β1 to induce EMT-related genes 
In addition to TGF-β, EMT is also shown to be regulated by other growth 
factors pathways, such as epidermal growth factor (EGF), fibroblast growth factor 
(FGF), and hepatocyte growth factor (HGF) pathways. Therefore, their ability to 
activate EMT in GIF-14 cells was investigated. In addition, the potential cooperation 
between TGF-β and these growth factors was also studied. Parental GIF-14 cells were 
treated with EGFs, FGFs, HGF and TGF-β1 alone or together with TGF-β1 for 24h 
and gene expression profiling of EMT- and mesenchymal-related genes was 
performed. The results showed that robust activation of Snai1, Fn1 and Hmga2 was 
observed when cells were singly treated with TGF-β1, but not EGFs, FGFs and HGF 
(Figure 4.13). Co-treatment of EGFs or HGF together with TGF-β1 resulted in greater 
activation of Snai1 and Hmga2 transcripts (Figure 4.13). These data show that TGF-β 
is the primary factor that induces the EMT signature, though some degree of 





























































































































































































































In the previous chapter, the P2 subpopulation in the GIF-14 cell line was 
found to have reduced epithelial characteristics. Thus, the possibility of GIF-14 cells 
undergoing EMT was investigated. Through time-lapse microscopy and gene 
expression profiling, the P2 subpopulation was shown to display mesenchymal-like 
features and was highly enriched for EMT- and mesenchymal-associated markers, 
indicating that the P2 cells are products of spontaneous EMT in GIF-14 cells. 
Furthermore, TGF-β1 treatment readily caused an expansion of the tumorigenic, 
Lgr5-positive P2 subpopulation as revealed by Hoechst 33342 staining, along with 
significant induction of EMT- and mesenchymal-related transcripts. These 
observations strongly implicate EMT as major contributor to the tumorigenicity of 
GIF-14 cells. However, it was noted that E-cadherin mRNA levels was comparable in 
P1 and P2 cells and its expression remained unaffected by TGF-β1 (Figures 4.3 and 
4.4). The reason for these observations is currently unclear though known repressors 
of E-cadherin such as Snai1 and Snai2 were induced. At this point, it has yet been 
demonstrated that Snai1 and Snai2 are responsible for driving the EMT phenotype in 
GIF-14 cells, thus they are viewed as markers for TGF-β responsiveness. It would be 
necessary to verify the protein expression and sub-cellular localisation of E-cadherin 
in P1 and P2 subpopulations. As reported in Section 3.1.2, the GIF cell lines exist in 
an immortalised but untransformed, pre-malignant state. Hence, tumour initiation and 
growth requires additional mutations and/or growth stimuli from a permissive tissue 
microenvironment. In this context, the reprogramming properties of EMT may 
contribute to tumor formation by conferring greater adaptability and increased 
resistance to apoptosis to ensure better survival in graft niche when transplanted. 
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Moreover, cells that have undergone EMT may be more responsive to growth factors 
present in the microenvironment.  
An unexpected and intriguing observation from this study is that prolonged 
TGF-β1 treatment induced Lgr5, hitherto known only as a Wnt target and an 
exclusive gastrointestinal stem cell marker (Figure 4.4) (Barker et al., 2007; Barker et 
al., 2010). This finding indicates that EMT promotes a stem cell-like state in GIF-14 
cells by imparting greater cellular plasticity. This observation is analogous to the 
recently reported phenomenon that aberrant activation of EMT in mammary epithelial 
cells would generate “cancer stem cells” (Mani et al., 2008). A key implication of this 
phenomenon is that differentiated cells can revert to a stem cell-like state through the 
reprogramming properties of EMT, which challenges existing dogmas of 
carcinogenesis (Mani et al., 2008; Morel et al., 2008).  
The phenotypic plasticity of GIF-14 cells was further demonstrated in two 
observations: 1) P1 readily took on a P2-like phenotype upon TGF-β1 treatment; and 
2) a gradient of epithelial and mesenchymal characteristics within individual P2 
colonies (Figures 4.7 and 4.8B). This phenomenon is akin to the intermediate 
“metastable” phenotype observed during EMT, in which co-expression of mixed 
epithelial and mesenchymal traits occur within the same cell population (Savagner et 
al., 2005). Interestingly, cells within the TGF-β1-treated P1 colonies displayed more 
drastic changes in membrane morphology than those in P2 colonies, suggesting that 
exogenous TGF-β1 and autocrine signals may induce different degree of 
“metastability” (Figure 4.8A). It would be worthwhile to investigate whether P2 cells 
could be further induced to completely lose epithelial characteristics by TGF-β1. The 
intermediate phenotype is considered unstable and contributes to the adaptability and 
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tumorigenicity of cells aberrantly altered by EMT. The co-existence and persistence 
of P1 and P2 in normal in vitro culture also suggests that a dynamic equilibrium may 
exist between P1 and P2. While epithelial-like P1 cells are primed to undergo EMT 
induced by TGF-β1 and Wnt3a (Figures 4.5, 4.6 and 4.7), P2 cells may revert to P1 
phenotype through a reverse process, i.e. Mesenchymal-Epithelial Transition (MET).  
An important observation from immuno-fluorescent staining experiments is 
the shift from membranous to nuclear staining of β-catenin when cells become more 
motile and detached at the boundary of P2 or TGF-β1 treated P1 colonies (Figure 
4.8B). This indicates an activated Wnt signaling which is reminiscent of the invasive 
front of metastatic tumours, where activation of TGF-β and Wnt pathways drives 
EMT and metastasis (Brabletz et al., 2005; Klymkowsky and Savagner, 2009). As the 
immuno-fluorescent data are qualitative in nature, these could be corroborated with 
biochemical approach such as subcellular fractionation combined with Western 
blotting to verify the changes in membrane, cytosolic and nuclear localisation. 
Consistent with the involvement of Wnt pathway in EMT, Wnt3a treatment in GIF-14 
cells induced EpCAMlowCD133- cells in a similar manner to TGF-β1 (Figure 4.6). It 
is plausible that TGF-β1 induces the Wnt pathway by depleting β-catenin at the 
adherens junctions which in turn cooperates with Wnt to reinforce EMT.  
The spontaneous emergence of P2 cells in GIF-14 cells suggests the existence 
of constitutively active EMT-inducing pathways due to autocrine growth factors. The 
identity of these signals was investigated through two approaches: 1) the addition of 
exogenous growth factors; and 2) the use of a specific inhibitor for the canonical 
TGF-β pathway. The data from these experiments provide evidence that an autocrine 
TGF-β pathway is responsible for the promotion and maintenance of the P2 
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subpopulation within GIF-14 cells, in a Smad2/3-dependent manner. This was 
confirmed by the remarkable reversal to an epithelial phenotype in the presence of 
TGF-β inhibitor as measured by cell morphology, gene expression and Hoechst 33342 
staining (Figures 4.9 to 4.12). These are concordant with the recent report that the 
maintenance of the mesenchymal state required sustained activation of TGF-β and 
Wnt pathways in an autocrine fashion in mammary epithelial cells. Importantly, 
disruption of autocrine signaling loops would suppress cell migration, self-renewal 
and tumorigencity (Scheel et al., 2011). In addition to the activation of Smads2/3, 
Smad–independent signaling such as the mitogen-activated protein kinase (MAPK) 
pathways, phosphatidylinositol 3-kinase-Akt and RhoA pathways are also involved in 
TGF-β-mediated EMT (Hartsough and Mulder, 1995; Atfi et al., 1997; Frey and 
Mulder, 1997; Hanafusa et al., 1999; Bakin et al., 2000; Bhowmick et al., 2001). For 
instance, TGF-β-mediated regulation of RhoA-GTPase activity through the 
Occludin/Par6/Smurf1 pathway at the tight functions of epithelial cells has been 
implicated in priming for EMT (Ozdamar et al., 2005). Activation of the Rho cascade 
induces the formation of stress fibres (Ridley and Hall, 1992) which was clearly 
observed in P2 and TGF-β1-treated P1 colonies. Therefore, the involvement of RhoA 
pathway in TGF-β-induced EMT could be investigated.  
Taken together, our results show that the GIF-14 cell line undergoes EMT 
readily induced by autocrine or exogenous TGF-β1 or Wnt3a to give rise to the 
tumorigenic, stem cell-like and mesenchymal-like P2 subpopulation characterised in 
Chapter 3. An unexpected degree of phenotypic plasticity was observed in GIF-14 
where P1 cells would dedifferentiate into the Lgr5-positive P2 cells through the 
reprogramming properties of EMT. The phenomenon of spontaneous EMT is likely to 
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be restricted to Runx3-/- GIF cell lines as Runx3+/+ lines are not tumorigenic and 
possess intact cell-cell adhesions (Li et al., 2002; Fukamachi et al., 2004). In view of 
the previous reports that Runx3-/- GIF cell lines were refractory to the growth 
suppressive and apoptotic effects of TGF-β1 compared to Runx3+/+ cells (Li et al., 
2002), it is surprising that Runx3-/- GIF-14 cells are susceptible to EMT-promoting 
effects of TGF-β1. Therefore, Runx3 may play an important role in modulating the 
TGF-β pathway. For this reason, the relationship between the loss of Runx3 and 











Runx3 safeguards gastric epithelial cells against aberrant 



















5.1.1 Runx3-/- GIF cell lines display altered differentiation and epithelial phenotype 
Despite the observation of a hyper-proliferative stomach in the Runx3-null 
mouse model, the study of Runx3 function in gastric epithelial cells was severely 
hampered by the early death (postnatal day1) of C57BL/6 Runx3-/- mice. To alleviate 
this problem, a series of mouse gastric epithelial cell lines, termed the GIF cell lines 
were established by the immortalisation of Runx3+/+.p53-/- or Runx3-/-.p53-/- gastric 
epithelial cells isolated from E16.5 fetuses. In the initial characterisation of these 
embryonic cell lines, it was revealed that when cultured between collagen sheets, 
Runx3+/+ GIF lines readily formed simple columnar epithelia with glandular 
structures. Like normal gastric epithelial cells, these cells exhibited polarity with 
mucus droplets localised on the luminal surface (Fukamachi et al., 2004). In contrast, 
Runx3-/- GIF lines under the same culturing conditions displayed an altered in vitro 
phenotype that was characterised by poor organisation and disrupted differentiation. 
Of particular note, these cells failed to develop apical-basal polarity and glandular 
structures (Fukamachi et al., 2004). The former was subsequently found to be caused 
by the reduced expression of tight junction proteins important for cell-cell contact, 
such as Claudin-1 which was found to be a positive target of Runx3 (Chang et al., 
2010). These data indicate that Runx3 is required for the proper differentiation into 
glandular epithelial sheet with established cell-cell adhesion and polarity in collagen 
gel cultures.  
When subcutaneously transplanted into immuno-compromised nude mice, it 
was found that only Runx3-/- GIF lines and not their Runx3+/+ counterparts were 
tumorigenic (Li et al., 2002). The resultant Runx3-/- GIF-generated tumours were 
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studied to provide further insights into their differentiation potentials. Remarkably, 
histological analysis of tumours in nude mice and in vitro culture in three dimensional 
matrigel showed that Runx3-/- GIF lines were capable of trans-differentiating into 
intestinal-type cells (Fukamachi et al., 2004; Fukamachi et al., 2008). Together, all 
the above data indicate that Runx3-/- cells are prone to losing their identity as gastric 
epithelial cells when perturbed by extracellular morphogenetic cues. These 
observations are further supported by recent finding from adult BALB/c Runx3-/- mice, 
which showed altered differentiation and intestinalisation of the gastric epithelium, 
characterised by the loss of chief cells and aberrant expression of the intestinal 
specific transcription factor Cdx2 (Ito et al., 2011). 
 
5.1.2 Altered TGF-β and Wnt signaling in Runx3-/- GIF lines 
A prominent feature of Runx3-/- GIF lines is their resistance to TGF-β1-
mediated growth arrest and apoptosis (Li et al., 2002). This is consistent with the 
critical function of RUNX3 as a mediator of the TGF-β/Smad tumour suppressor 
pathway in gastric epithelial cells. Through direct interactions with the Smad 
transcription factors, RUNX3 transcriptionally activate the expression of p21WAF/Cip1 
and BIM, a negative regulator of cell cycle and a pro-apoptotic gene respectively (Chi 
et al., 2005; Yano et al., 2006; Ito 2008). Indeed, the ability to escape TGF-β-
mediated apoptosis is considered to be an important basis for the tumorigenicity of the 
Runx3-/- GIF lines. However, the TGF-β signaling pathway is remarkably pleiotropic 
in that while it serves as a major cancer barrier in early carcinogenesis due to its 
tumour suppressive activities, its ability to aberrantly activate EMT renders it a major 
driver of cancer progression and metastasis in late stage cancers (Wakefield and 
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Roberts, 2002). It is therefore possible that the resistance of Runx3-/- GIF lines to 
TGF-β-mediated apoptosis is a result of the skewing of TGF-β signaling towards 
EMT-activating properties due to the absence of Runx3. Apart from its involvement 
in TGF-β signaling, RUNX3 acts as a molecular antagonist to the canonical Wnt 
pathway through direct interaction with the TCF4/β-catenin complex in human 
colorectal cancer cell lines (Ito et al., 2008). Consistent with this, Runx3-/- intestinal 
epithelial cells in primary cultures displayed higher sensitivity to Wnt stimulation 
than their Runx3+/+ equivalents (Ito et al., 2008). However, the response to Wnt 
signaling has yet been addressed in gastric epithelial cells. In our study, Wnt 
responsiveness was demonstrated in the Runx3-/- GIF-14 cell line through the 
activation of Lgr5 by Wnt3a. Hence, Runx3 is also involved in modulating the Wnt 
pathway in the stomach and the dysregulation of which is heavily implicated in 
gastrointestinal neoplasia as well as aberrant activation of EMT (Brabletz et al., 2001; 
Kim et al., 2002, Kolligs et al., 2002; Vincan and Barker, 2008).  
In the previous chapter, it was demonstrated that the Runx3-/- GIF-14 cell line 
underwent spontaneous EMT to give rise to a tumorigenic and stem cell-like P2 
subpopulation. This was attributed to a constitutively active TGF-β pathway caused 
by an autocrine TGF-β loop in GIF-14 cells during normal in vitro culture. 
Furthermore, the canonical Wnt pathway was also shown to promote the formation of 
EpCAMlowCD133-/P2 subpopulation. Given that Runx3 is involved in both TGF-β 
and Wnt pathways, the roles of Runx3 in EMT and tumorigenicity of gastric epithelial 
cells will now be investigated through the use of Runx3-null and Runx3-expressing 




5.1.3 Experimental approach 
The contribution of Runx3 in the regulation of EMT would be studied by two 
approaches: 1) Comparing the TGF-β and Wnt responsiveness of Runx3+/+ and 
Runx3-/- GIF cell lines; and 2) Studying the effects of exogenous RUNX3 on the TGF-
β and Wnt responsiveness of Runx3-/- GIF-14 cells. For the former, TGF-β and Wnt 
responsiveness of multiple Runx3+/+ and Runx3-/- GIF cell lines would be quantified 
and compared. To accomplished the latter, lentiviruses will be employed which 
enables the sustained and stable expression of RUNX3 due to their ability to integrate 
into the host genome following transduction (Naldini et al., 1996; Kafri et al., 1997; 
Miyoshi et al., 1997).  Furthermore, lentiviruses are capable of delivering the 
transgenes into dividing as well as non-dividing cells (Burkrinsky et al., 1993), hence 
enabling the study of all subpopulations within the GIF-14 cell line. The response of 
multiple GIF lines to various treatments and exogenous RUNX3 will be quantified by 












5.2.1 Runx3-/- GIF lines are sensitised to TGF-β1-induced EMT 
To investigate whether the reduced epithelial and EMT-prone phenotype 
observed was a unique characteristic of GIF-14 cells or a general phenomenon among 
the Runx3-/- GIF cells lines, the expression of EpCAM and CD133 were measured in 
four individual Runx3-/- and Runx3+/+ GIF cell lines. Flow cytometry analyses 
revealed that the EpCAMlowCD133- fraction associated with the tumorigenic, 
mesenchyml-like P2 cells in GIF-14 was significantly represented only in Runx3-/- 
GIF-5 and GIF-14 cells. Moreover, the average expression of EpCAM was also 
significantly lower in Runx3-/- cell lines, reflecting an overall loss of epithelial 
phenotype (Figure 5.1A). The loss of epithelial characteristics in Runx3-/- cell lines is 
in agreement with published reports in which these cell lines showed defective 
epithelial morphology when grown in collagen cultures (Fukamachi et al., 2004). The 
relative expression of Runx3 in these GIF cell lines was assessed by Western blotting 
using two separate Runx3-specific monoclonal antibodies, R3-5G4 and -8C9. This 
also confirmed the absence of contaminating Runx3-expressing cells in Runx3-/- GIF 











Figure 5.1. EpCAM/CD133 antigen profiles and the expression of Runx3 in Runx3-/- and Runx3+/+ GIF 
cell lines. (A) Runx3+/+ (GIF-9 and GIF-13) and Runx3-/- (GIF-5 and GIF-14) cell lines were subjected to 
co-staining of antibodies against surface markers EpCAM and CD133 and analysed on the flow 
cytometer. To determine the relative expression levels of Runx3, total cell lysates were used in Western 
blot analysis (Section 2.14) using anti-Runx3 monoclonal antibodies (B) R3-5G4 and (C) R3-8C9. As 




The reduced epithelial characteristics in Runx3-/- lines suggest that they may be 
prone to undergo EMT. To test this, Runx3-/- and Runx3+/+ lines were treated with 
TGF-β1 and changes in gene expression was measured by qRT-PCR. This revealed 
remarkable differences in TGF-β1 responsiveness between the two groups. In Runx3-
null GIF-5 and GIF-14 lines, induction of EMT- and mesenchymal-related marker 
genes were observed within 24h, with the levels of Snai1 prominently elevated 
(Figure 5.2). In contrast, only marginal induction of these marker genes were 
observed in Runx3+/+ GIF-9 and GIF-13 lines (Figure 5.2). These results provide 
sufficient evidence that an important function of Runx3 in gastric epithelial cells is to 























































































































































































































































































































5.2.2 Exogenous RUNX3 reduces the P2 subpopulation 
To verify the negative correlation between Runx3 and mesenchymal-like 
phenotype in Runx3-/- GIF lines, wild-type human RUNX3 and RUNX3R178Q were 
stably re-introduced into Runx3-null GIF-14 cells by lentiviruses. RUNX3R178Q is a 
DNA-binding defective mutant of RUNX3 which bears an amino acid substitution of 
arginine to glutamine in the Runt domain and used as a negative control (Inoue et al. 
2007). As RUNX3/RUNX3R178Q was cloned upstream of the IRES-EGFP sequences in 
the iG2 lentiviral vector (Section 2.12.1), RUNX3/RUNX3R178Q and enhanced green 
fluorescent protein (EGFP) could be co-expressed in infected cells. Thus, this strategy 
enables the tracing of transduced cells by flow cytometry and fractionation by FACS 
based on stable expression of EGFP. The transduction effeciency achieved by iG2 
lentiviruses was approximately 50%. However, the percentage of EGFP+ cells in iG2-
RUNX3 infected samples would steadily decline over the course of an experiment, 
indicating that RUNX3 exerts a negative selection pressure that is consistent with its 
tumor suppressor activity. GIF-14 cells transduced with lentiviruses encoding iG2-
Control, iG2-RUNX3 or iG2-RUNX3R178Q were subjected to Hoechst 33342 staining 
and analyses by flow cytometry 4 and 6 days post-infection. The ectopic expression of 
RUNX3 markedly altered the Hoechst 33342 staining profile. RUNX3 caused a 
reduction of P2 subpopulation 4 days post-infection and this trend was persistent and 
further enhanced at six days post-infection (Figure 5.3). In contrast, stable 
introduction of RUNX3R178Q resulted in Hoechst 33342 staining pattern 
indistinguishable from that of cells infected with the iG2-Control lentivirus. This 
indicates that the effect of RUNX3 is dependent on its DNA-binding activity (Figure 
5.3). To demonstrate that there is a close coupling of EGFP expression and that of 
ectopic proteins, EGFP+ and EGFP- cells were fractionated and analysed by Western 
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blot using RUNX3-specific R3-5G4 antibody. This revealed that exogenous proteins 
were detectable in the EGFP+ but not in EGFP- fractions, indicating that the purity of 
the FACS-enriched cells was high (Figure 5.3). The expression levels of exogenous 
RUNX3/RUNXR178Q were estimated to be ~130-fold that of endogenous Runx3 in 
GIF-13 cells relative to α-tubulin (data not shown). 
 
Figure 5.3. Optimisation of lentivirus transduction for the over-expression of RUNX3 in GIF-14 cells. 
GIF-14 cells were transduced with lentiviruses encoding encoding wild-type RUNX3 or its DNA-binding 
defective mutant, RUNX3R178Q. Transduction efficiency was determined by the percentage of EGFP+ 
cells and the Hoechst 33342 staining patterns in EGFP+ cells were analysed by flow cytometry 4 and 6 
days post-transduction. PI denotes propidium iodide. The expression of exogenous proteins in FACS-
enriched GIF-14 cells 6 days post-transduction was confirmed by Western blot analysis. Exogenous 
RUNX3 amd RUNX3R178Q was detected using R3-5G4 antibody. Immunoblotting of α-tubulin was 






The results from the previous experiment showed that at least six days of 
infection was required for RUNX3 to exert pronounced effects, this infection regime 
was employed in the subsequent sections. GIF-14 cells were transduced with 
lentiviruses encoding iG2-Control, iG2-RUNX3 or iG2-RUNX3R178Q. At two days 
post-infection, cells were treated with TGF-β1 for 4 days prior to Hoechst 33342 
staining for flow cytometric analysis. Three separate experiments were performed and 
the FACS plots from a representative experiment were shown in Figure 5.4A. Our 
results revealed that ectopic expression of RUNX3 resulted in an ablation of the P2 
subpopulation and this effect was augmented when cells were treated with TGF-β1 
(Figure 5.4A). The data from three experiments were compiled in which P2 cells was 
presented as a percentage of combined P1 and P2 cell populations (Figure 5.4B). 
Importantly, the Hoechst 333242 staining pattern from RUNX3R178Q infected cells 
was indistinguishable from that of the iG2-Control, confirming that the effect of 
RUNX3 is dependent on its DNA-binding activity (Figures 5.4A and 5.4B). 
Interestingly, over expression of RUNX3 also caused P1 cells to display lower dye 
efflux capacity (Figure 5.4A), possibly due to a downregulation of the ATP binding 
cassette protein transporters by RUNX3.  
As P1 and P2 cells could be demarcated based on their differential EpCAM 
and CD133 expression, changes in these markers were also determined by flow 
cytometry and expressed as a percentage of combined EpCAMhighCD133+ and 
EpCAMlowCD133- populations. Consistent with the Hoechst 33342 staining data, 
exogenous RUNX3 but not RUNX3R178Q reduced the P2-associated 
EpCAMlowCD133- fraction. In addition, an increase in the P1-associated 
EpCAMhighCD133+ fraction in RUNX3 infected cells was observed (Figure 5.4C). 
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Therefore, our data suggest that exogenous RUNX3 exerts an antagonistic effect on 







Figure 5.4. The effects of exogenous RUNX3 on Hoechst 33342 staining and EpCAM/CD133 profiles 
in GIF-14 cells. (A) GIF-14 cells were transduced with EGFP-tagged iG2-Control, -RUNX3 or -
RUNX3R178Q lentiviruses for 48h preceding the treatment with 2.5ng/ml of TGF-β1 for 4 days. EGFP+ 
infected cells were subjected to Hoechst 33342 staining and analysed by flow cytometry. Profiles of 
EGFP- cells served as negative controls. The experiments were performed in triplicates and the 
FACS charts from one representative experiment were shown here. (B) Changes in the P2 
subpopulation following TGF-β1 treatment in EGFP+ cells in three separate experiments were 
compiled. The relative levels of P2 cells are presented as a percentage of P1 and P2 combined 
values (means ± SEM, n=3). (C) Corresponding changes in EpCAM and CD133 surface antigen 
expression in EGFP+ cells from three independent experiments were compiled. The relative levels of 
EpCAMhighCD133+ and EpCAMlowCD133- populations are presented as a percentage of their 
combined values (means ± SEM, n=3). Single and double asterisks represent p-value <0.05 and p-
value <0.01, respectively.    
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5.2.3 RUNX3 suppresses TGF-β1-induced EMT-related genes and Lgr5 
To assess the effect of RUNX3 on TGF-β1-induced genes, gene expression 
profiling was performed. Three independent infections were set up as described in 
Section 5.2.2, with the exception that GIF-14 cells were infected for 6 days prior to 
24h of TGF-β1 treatment. Infected cells were enriched by FACS based on EGFP 
fluorescence and harvested for qRT-PCR analyses. The results showed that RUNX3 
partially and completely abrogated TGF-β1-induced Snai1 and Hmga2 respectively, 
but not RUNX3R178Q (Figure 5.5). As TGF-β1 treatment was shown to activate Lgr5 
in Section 4.2.2, the effect of RUNX3 on TGF-β-induced Lgr5 was therefore tested. 
The results showed that exogenous RUNX3 strongly inhibited TGF-β1-induced Lgr5 
and Sox9. Interestingly, the basal expression of these genes was also suppressed by 
RUNX3 in contrast to those of Snai1 and Hmga2 (Figure 5.5). Together, these data 
indicate that RUNX3 plays a negative role in the regulation of TGF-β1-induced EMT 
genes and Lgr5 in a DNA-binding dependent manner. To confirm the expression of 
exogenous proteins, Western blotting was performed, which revealed that exogenous 
RUNX3 and RUNX3R178Q were expressed at comparable levels in lentivirus-




Figure 5.5. Changes in EMT- and stemness-related genes in the presence of exogenous RUNX3. (A) 
GIF-14 cells were treated with TGF-β1 for 24h following 6 days of infection by lentiviruses encoding 
Control, RUNX3 or RUNX3R178Q. EGFP+ infected cells were enriched by FACS and changes in EMT- 
and stemness-associated markers were measured by qRT-PCR. Three separate infection experiments 
were carried out and the expression levels were normalised against those of Gapdh and presented as a 
ratio to the untreated iG2-Control sample for individual genes (means ± SEM, n=3). Single and double 
asterisks represent p-value <0.05 and p-value <0.01, respectively. Western blotting was performed to 
confirm the expression levels of exogenous RUNX3 and RUNX3R178Q 48h post-infection using R3-5G4 




5.2.4 Runx3-/- GIF cells display increased Wnt responsiveness 
The Wnt target gene and stem cell marker Lgr5 was shown to be highly 
induced by Wnt3a-Cm in Runx3-/- GIF-14 cells in Section 3.2.7. As RUNX3 is known 
to be a potent molecular antagonist of the Wnt pathway through its direct interaction 
with the TCF4/β-catenin complex, the Wnt responsiveness of Runx3-/- and Runx3+/+ 
cells were compared (Ito et al., 2008). GIF-14 (Runx3-/-) and GIF-13 (Runx3+/+) cells 
were treated with Wnt3a- or Control-Cm for 15h and the expression of Lgr5 transcript 
was ascertained by qRT-PCR. The results revealed that GIF-14 cells were highly 
sensitised to Wnt3a-Cm as reflected in the strong induction of Lgr5 while GIF-13 
cells were not responsive to Wnt3a (Figure 5.6).  Moreover, GIF-14 cells showed a 6-
fold greater basal expression of Lgr5 than GIF-13 cells, indicative of a constitutively 
active Wnt signaling (Figure 5.6). These data indicate that similar to earlier 
observations in colorectal epithelial cells, Runx3 has an inhibitory effect on the 
canonical Wnt pathway in GIF cells.  
                
Figure 5.6. Comparison of Wnt responsiveness of Runx3-/- and Runx3+/+ GIF cell lines. Runx3-/- GIF-14 
and Runx3+/+ GIF-13 lines were treated with Control or Wnt3a-Cm diluted 1:3 by culture medium for 15h 
prior to measurement of Lgr5 transcripts by qRT-PCR. The expression levels were normalised against 
those of Gapdh and expressed relative to GIF-14 treated with control-Cm. Double asterisks denotes p-
value < 0.01. 
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To assess whether higher basal Lgr5 expression correlates to increased sphere 
formation, the sphere-forming potential of Runx3-/- GIF-14 and Runx3+/+ GIF-13 cells 
were compared. These two cell lines were cultured in serum-free sphere medium and 
the number of spheres was scored. The results revealed that GIF-14 cells possessed 4-
fold higher sphere-forming activity than GIF-13 cells (Figure 5.7). While spheres 
formed by GIF-14 cells could be maintained for a long period of time, GIF-13 cells 
gave rise to sphere-like structures that quickly disintegrated into clusters of mixed cell 
morphologies indicative of differentiation (Figure 5.7). Collectively, these data 
indicate that Runx3 is a negative regulator of a stem cell-like state through the 
suppression of Lgr5 and sphere formation. 
   
     
Figure 5.7. Relative sphere-initiation potential of GIF-14 and GIF-13 cells. Sphere-forming assay was 
set up using GIF-14 and GIF-13 cells in the presence of 0.1% of methylcellulose as described in 
materials and methods. Data are presented as number of spheres (≥250µm in size) generated from 
5000 cells after 25 days in culture (means ± SEM, n=4). Double asterisks denotes p-value < 0.01. 




5.2.5 Exogenous RUNX3 abrogates Wnt3a-induction of Lgr5 and sphere formation 
To verify the negative role of Runx3 on the canonical Wnt pathway in GIF 
gastric epithelial cells, exogenous wild-type RUNX3 or RUNX3R178Q (a DNA-binding 
defective mutant) were ectopically introduced into Runx3-null GIF-14 cells by the 
pBOBI series of lentiviruses. As the transduction efficiency for these viruses was 
approximately 80%, the cells were harvested in situ following 15h of Control- or 
Wnt3a-Cm treatment, without enrichment by FACS. Our results revealed that 
RUNX3 partially abrogated the robust induction of Lgr5 by Wnt3a while the ectopic 
expression of RUNX3R178Q had no effect (Figure 5.8). These data indicate that 
RUNX3 antagonises the canonical Wnt pathway in a DNA-binding dependent manner 
in gastric epithelial cells. The relative expression of exogenous proteins in GIF-14 
cells was assessed by Western blot analysis. This confirmed that the expression levels 





Figure 5.8. The effects of exogenous RUNX3 on Wnt3a-induced Lgr5. (A) GIF-14 cells were infected 
with pBOBI-Control, -RUNX3 or -RUNX3R178Q lentiviruses for 48h preceding treatment with control or 
Wnt3a-Cm (1:3 dilution with culture medium) for another 15h. Cells were harvested for quantification of 
Lgr5 mRNA levels by qRT-PCR. Values are normalised against those of Gapdh and expressed as ratios 
to that of control-Cm treated cells for each sample. Double asterisks denotes p-value < 0.01. (B) GIF-14 
cells were transduced with the pBOBI-based series of lentiviruses for 48h. The expression levels of 
exogenous proteins were confirmed by Western blot analysis 48h post-infection using R3-5G4 antibody. 




The strong inhibition of Wnt3a-induction of Lgr5 by exogenous RUNX3 
prompted the testing of its effect on sphere formation. GIF-14 cells were infected with 
lentiviruses encoding wild-type RUNX3 or iG2-Control for 6 days and subjected to 
enrichment by FACS. Sphere-forming capacities of FACS-purified cells were 
evaluated. The results revealed that ectopic expression of RUNX3 dramatically 
reduced sphere formation by 4-fold compared to iG2-Control (Figure 5.9A). In a 
similar experiment, GIF-14 cells infected with wild-type RUNX3 or iG2-Control 
viruses were pre-treated with Control- or Wnt3a-Cm prior to purification by FACS. 
Sphere-forming assay was performed on enriched cells cultured in Control- or Wnt3a-
Cm diluted 1:10 by sphere medium. Under this condition, ectopically expressed 
RUNX3 consistently suppressed sphere-formation (Figure 5.9B).  Moreover, RUNX3 
also completely blocked the induction of sphere-formation by Wnt3a (Figure 5.9B). 
Together, these data clearly demonstrate that RUNX3 acts as a negative regulator of 










Figure 5.9. The effects of exogenous RUNX3 on sphere-initiation. (A) GIF-14 cells were transduced 
with lentiviruses encoding Control, RUNX3 or RUNX3R178Q. Six days post-infection, EGFP+ cells were 
fractionated by FACS and cultured in sphere medium containing 0.5% of methylcellulose. Spheres 
(≥150µm in size) generated from 8000 cells were counted after 34 days of culture (means ± SEM, n=5). 
Double asterisks denotes p-value < 0.01. Phase contrast images of spheres are shown. Scale bars, 
300µm. (B) Transduced GIF-14 cells were pre-treated with control or Wnt3a-Cm for 2 days prior to 
enrichment of EGFP+ cells by FACS 6 days post-infection and sphere-forming assay was performed. 
Conditioned media was supplied in 1:10 dilution with sphere medium containing 1% of methylcellulose. 
Number of spheres formed from 8000 cells was scored 25 days after culture (means ± SEM, n=5). 




5.2.6 Runx3 abrogates the synergistic activation of Lgr5 by TGF-β and Wnt3a 
To investigate the tripartite relationship between EMT, stemness and Runx3, a 
co-induction with TGF-β1 and Wnt3a was performed on GIF-14 (Runx3-/-) and GIF-
13 (Runx3+/+) cells. Cells were pre-treated with TGF-β1 for varying periods before 
they were co-treated with control- or Wnt3a-Cm for a further 15h. Quantitative RT-
PCR measurement of Lgr5 and Snai1 of treated cells revealed distinct induction 
patterns in GIF-14 cells. Notably, Snai1 was strongly activated by TGF-β1 within 15h 
of treatment, but was unresponsive to Wnt3a (Figure 5.10). In comparison, Lgr5 
transcript was initially suppressed by TGF-β1 at 15h, but was moderately induced 
upon prolonged treatment for 48h. Surprisingly, Wnt3a-induction of Lgr5 was 
dramatically augmented with TGF-β1 pre-treatment for 48h from 9-fold to 30-fold. 
This synergistic effect was not observed at shorter TGF-β1 pre-treatment time points 
(Figure 5.10). These data implies that the strong synergy between TGF-β1 and Wnt3a 
in activating Lgr5 transcription involves an independent but cooperative mechanism. 
Remarkably, the Wnt3a- and TGF-β1-responsiveness observed for these two genes 
was completely muted in Runx3+/+ GIF-13 cells, underscoring the strong opposing 




























































































































































































































































































































The identification of a tumorigenic and stem cell-like subpopulation in the 
Runx3-/- GIF-14 cell line and the discovery of its induction by TGF-β1 and Wnt3a 
signals raised important questions. These pathways are critical for the development, 
homeostasis and carcinogenesis in the gastrointestinal tract and RUNX3 is known to 
act in cooperation or in antagonism with them in this specific context (Chi et al., 2005; 
Yano et al., 2006; Ito et al., 2008). This chapter addresses the relationship between 
the absence of Runx3 and the susceptibility to spontaneous EMT in gastric epithelial 
cells; and to further understand the contribution of the dysregulated TGF-β and Wnt 
pathways to the observed cellular plasticity. 
The cell surface markers analysis revealed that Runx3-/- GIF lines displayed a 
reduced epithelial phenotype that is in contrast to Runx3+/+ lines (Figure 5.1A). 
Indeed, further analysis showed that the Runx3-/- GIF cells lines were highly sensitised 
for TGF-β1-induced expression of EMT- and mesenchymal-associated markers 
(Figure 5.2). This is a paradoxical and intriguing observation as it was previously 
reported that Runx3-/- GIF lines were refractory to TGF-β1-induced apoptosis, 
consistent with the tumour suppressor activity of RUNX3 (Li et al., 2002). The data 
from the current study suggests that in the absence of Runx3, the TGF-β signal would 
be diverted from its tumour suppressive and growth modulating functions, towards its 
EMT-inducing, morphogenetic functions. This point could be tested by analysing 
activation of the components or target genes of TGF-β-induced growth inhibition and 
EMT pathways through biochemical methods. These results further suggest that the 
pleiotropic effects of TGF-β pathway in gastrointestinal carcinogenesis could be due 
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to the silencing or mutation of an integral component, such as a partner transcription 
factor like RUNX3.  
A negative role of Runx3 in EMT is supported in the reduction of P2 cells by 
exogenous RUNX3 in GIF-14 cells as revealed by Hoechst 33342 staining (Figure 
5.4A and B). Moreover, the re-introduction of RUNX3 also caused a partial blockade 
of TGF-β1-induced key EMT-promoting factors, Snail and Hmga2 in a DNA-binding 
dependent manner (Figure 5.5A) Apart from being a negative regulator of EMT, 
RUNX3 strongly antagonises TGF-β1-induced stem cell-like state as demonstrated in 
the complete abrogation of stemness-related markers, Lgr5 and Sox9 induced by TGF-
β1. However, unlike Snai1 and Hmga2, the basal levels of Lgr5 and Sox9 were also 
suppressed by ectopic RUNX3 (Figure 5.5A). As Lgr5 and Sox9 are also known Wnt 
targets, this observation could be due in part to the antagonistic function of RUNX3 
against the canonical Wnt pathway, as reported in intestinal epithelial cells (Ito et al., 
2008). Indeed, the altered response to extracellular cues observed in Runx3-/- GIF cell 
lines is not restricted to TGF-β signaling, but also the Wnt pathway. GIF-14 cells 
were sensitised to Wnt3a-induction of Lgr5 and formed spheres more readily 
compared to Runx3+/+ GIF-13 cells (Figures 5.6 and 5.7). This negative correlation 
between Runx3-deletion and sphere initiation was further supported by the 
abolishment of Wnt3a-induction of Lgr5 and sphere formation by exogenous RUNX3 
(Figures 5.8A and 5.9). Together, these data demonstrate that Runx3 acts as a barrier 
to the acquisition of stem cell-like or plastic state induced either by TGF-β1 or Wnt3a. 
The negative effects of ectopic RUNX3 on EMT and sphere formation were apparent 
only 6 days after lentivirus-mediated delivery. These observations are surprising as 
RUNX3 is known to regulate gene expression through direct transcriptional control. It 
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is possible that RUNX3 could act through an indirect mechanism in which its target 
gene is a transcription regulator. Alternatively, RUNX proteins has been reported to 
control gene expression by remodeling the chromatin structure through interactions 
with proteins such as histone deacetylases and p300 (Kitabayashi, et al. 1998; 
Lutterbach et al. 2000; Amann et al. 2001; Westendorf et al. 2002; Schroeder et al. 
2004). Therefore, RUNX3 could function through epigenetic mechanisms and these 
global changes may occur in a progressive manner. 
Lastly, the combined effects of dysregulated TGF-β and Wnt signaling were 
seen in their strongly cooperative induction of Lgr5 in GIF-14 cells. A notable aspect 
of this observation is that the two treatments induced Lgr5 expression with different 
kinetics. While Wnt3a transiently activated Lgr5, the effect of TGF-β1 was latent 
(Figure 5.10). The delayed actions of TGF-β1 may indicate that its effects were 
indirect and possibility acting through intermediate effectors. Alternatively, TGF-β1 
may function via epigenetic mechanisms involving the remodeling of chromatin 
structures, which makes the Lgr5 locus more accessible to transcription factors. 
Indeed, this increased accessibility may be the basis of the strong cooperation 
between TGF-β1 and Wnt3a in inducing Lgr5 at the later time point (Figure 5.10). 
The implication herein is that the reprogramming properties of EMT induced by an 
aberrant TGF-β signal would increase cellular plasticity, as reflected in the 
reactivation of Lgr5. This in turn sensitises cells to the mitogenic effects of the Wnt 
pathway. In GIF-14 cells, these compounding defects are causal to the genesis of the 
tumorigenic and stem cell-like P2 subpopulation. This novel molecular mechanism 
may underlie the tumorigenicity of all Runx3-/- GIF cell lines. Finally, our findings 
may also provide an explanation for the increased phenotypic plasticity and 
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precancerous conditions observed in adult BALB/c Runx3-/- gastric mucosa, 
characterised by hyperproliferation, development of preneoplastic metaplasia (SPEM) 























6.1 Summary of findings 
Based on the data presented in this study, a model is illustrated in Figure 6.1, 
where a tumorigenic and mesenchymal-like subpopulation, P2 was identified in the 
Runx3-/-.p53-/- GIF-14 cell line. Interestingly, the P2 subpopulation expresses high 
levels of Lgr5 which is a target gene of the canonical Wnt pathway, and a 
gastrointestinal stem cell marker. The P2 subpopulation arises through the induction 
of spontaneous EMT by a constitutively active TGF-β pathway. Moreover, Runx3-/- 
GIF-14 cells were prone to the induction of Lgr5 and stemness by Wnt3a. The 
combined effects of overly active TGF-β and Wnt pathways led to the synergistic 
induction of Lgr5 expression through cooperative but independent mechanisms. These 
defects were largely restricted to Runx3-/- GIF cell lines, and not observed in Runx3+/+ 
lines. Furthermore, the re-introduction of exogenous RUNX3 in GIF-14 cells led to an 
ablation of P2 cells, suppression of TGF-β1-induced EMT- and stemness-related 
genes, and abrogation of Wnt3a-induction of Lgr5, confirming the negative effect of 
RUNX3 on EMT and stemness. Collectively, our results demonstrate the critical role 
of Runx3 in maintaining the gastric epithelial cell phenotype, the absence of which 
predisposes cells to EMT-induced phenotypic plasticity and the appearance of a 
tumorigenic and stem cell-like subpopulation.   
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Figure 6.1. A model summarising the role of Runx3 in protecting gastric epithelial cells against EMT-

















6.2 Significance of findings  
The model of carcinogenesis that involves cumulative genetic mutations 
typically in tumour suppressors and oncogenes is a well established paradigm. These 
genetic alterations drive the immortalisation and eventual transformation of normal 
cells into their malignant derivatives (Nowell, 1976). The multi-step progression of 
tumours is thought to follow a sequence of clonal successions which ultimately 
produces a malignant clone most suitable for uncontrolled proliferation in the micro-
environment (Nowell, 1976). Recent data from the study of leukemias have revealed 
that the maintenance and continual evolution of a malignant clone is supported by a 
small minority of cells, termed “cancer stem cells”. Based on their existence, a refined 
model that holds a hierarchical organisation exists within a tumour mass, and the 
tumour is propagated by a small subpopulation of cancer cells (Lapidot et al., 1994; 
Clarke et al., 2006).  
Related to the advent of the cancer stem cell theory, recent discovery of 
aberrant EMT reactivation could generate a stem cell-like state in differentiated 
mammary epithelial cells further challenge the stem cell origin of cancer (Mani et al., 
2008; Morel et al., 2008). The ability of differentiated tumour cells to dedifferentiate 
into stem cell-like, tumour-initiating cells in vivo might resolve some of the 
conceptual difficulties over the cell-of-origin of cancer. In particular, the observed 
multipotency of EMT-induced “cancer stem cells” argues that cancer need not to be 
derived from mutated stem cells, but could derive from differentiated cells (Scheel 
and Weinberg, 2011). Therefore, EMT has emerged as an important path to a state of 
phenotypic plasticity, enabling cancer cells to dynamically enter into and exit from 
stem cell-like state. This notion is strongly supported by our observation that 
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spontaneous EMT promotes the emergence of a stem cell-like subpopulation within a 
Runx3-/- gastric epithelial cell line, that is concurrently tumorigenic. Furthermore, it 
implicates a safeguarding role for Runx3 against EMT-induced cellular plasticity and 
tumour-initiation in gastric epithelial cells, thus fulfilling its tumour suppressor 
function.  
Analogous to the reprogramming properties of EMT to induce phenotypic 
plasticity, the recently described somatic cell reprogramming has succeeded in 
converting differentiated cells to pluoripotent stem cells. Of relevance to our study, 
p53 is shown to play an important regulatory role in both EMT and somatic cell 
reprogramming. Inactivation of the p53-related pathways was required to greatly 
enhance the generation of induced pluoripotent stem (iPS) cells, through the escape of 
p53-mediated senescence and apoptosis (Hong et al., 2009; Kawamaura et al., 2009; 
Li et al., 2009; Marion et al., 2009; Utikal et al., 2009) Similarly, inactivation of p53 
function that enabled cells to evade senescence and apoptosis facilitated the induction 
of EMT by Twist and Zeb1 proteins as well as growth factors such TGF-β and EGF 
(Ansieau et al., 2008; Liu et al., 2008; Araki et al., 2010; Ohashi et al., 2010). Thus, it 
is plausible that the immortalisation of GIF cell lines against a p53-/- background may 
reduce the threshold for the induction of EMT. Given that the Runx3+/+.p53-/- 
remained resistant to EMT, the protective role of Runx3 against EMT-induced 
cellular plasticity is highlighted even in the absence of p53. 
The representation of stem cell-like cells within tumour cell populations in 
vivo is likely to be influenced by both the intrinsic phenotypic plasticity of these cells 
and contextual signals (Chaffer et al., 2011). The spontaneous conversion of a stem 
cell-like subpopulation in GIF-14 cells may be augmented in vivo by contextual cues 
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in the tumour niche, particularly those that drive the EMT. TGF-β and the Wnt 
pathways are the best known activators of EMT, and the dysregulation of these 
signaling pathways would collaborate to amplify the induction of EMT and cellular 
plasticity. This cooperation is clearly demonstrated in the synergistic induction of 
Lgr5 by TGF-β1 and Wnt3a in Runx3-/- GIF-14 cells, but not in Runx3+/+ GIF-13 cells. 
Therefore, an important part the tumour suppressor function of RUNX3 is to ensure 
that TGF-β and Wnt signaling pathways are properly regulated. In the case of TGF-β 
pathway, it is conceivable that Runx3 acts as a molecular switch to transduce the 
tumour suppressive functions of TGF-β and inhibit its EMT-promoting effects by 
orchestrating a set of genetic programs in gastric epithelial cells. In the absence of 
Runx3, the transcriptional circuitry would be disrupted and this is reflected in the 
ability of Runx3-/- GIF lines to bypass the tumour suppressive effects of TGF-β1, 
while becoming sensitised to its EMT-inducing functions.  
132 
 
6.3 Future work  
The precise mechanism through which Runx3 interferes with the EMT process 
remains unknown. Two complementary approaches could be carried out to elucidate 
this: 1) genome-wide comparative study of P1 and P2 cells to identify putative 
regulators of EMT; and 2) investigate the potential candidates of RUNX3 target genes. 
An important finding uncovered from this study is the existence of two distinct 
cellular states P1 and P2 within the GIF-14 cells, thus genome-wide microarray of P1 
and P2 cells would shed light on the potential key regulators of EMT. As TGF-β 
signaling pathway is a well-established central player in EMT in our model, several 
candidates mediating the effects of TGF-β have been found. One of the promising 
candidates is Hmga2, a non-histone chromatin protein which acts as a architectural 
factor that alters the chromatin structure, and promotes the assembly of protein 
complexes to regulate transcription (Fusco and Fedele, 2007). This was demonstrated 
in the cooperation of HMGA2 and Smads to transactivate the transcription of Snai1 in 
mammary epithelial cells (Thuault et al., 2008).  To gain an insight into the global 
epigenetic changes mediated by Hmga2, genome-wide chromatin immuno-
precipitation (ChIP) of Hmga2 will be performed upon ectopic Hmga2 expression in 
GIF cells. To demonstrate that Hmga2 is a direct target of RUNX3, promoter studies 
could be performed in which Hmga2 proximal promoter and intronic enhancers 
containing putative Runx binding sequences will be cloned to study the effects of 
exogenous RUNX3 on these cis-regulatory elements. 
The discovery of a negative role of Runx3 in protecting gastric epithelial cells 
against EMT-mediated cellular plasticity is made in immortalised GIF cell lines. 
These lines are pre-conditioned to undergo EMT in the absence of p53 and Runx3. To 
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validate these data in vivo, conditional targeting of Runx3 using stomach-specific Cre 
recombinase will be performed to assess whether the loss of Runx3 would cause 
greater phenotypic plasticity in the gastric mucosa. To complement this, ex vivo 
culture systems using normal gastric epithelial cells and stem cells will be employed. 
Previously, Barker et al. succeeded in generating long-lived gastric organoid 
structures from single Lgr5-positive pyloric stomach stem cells. The gastric organoid 
cultures would serve as an important platform for in vitro deletion of Runx3 in normal 
gastric epithelial cells, and specifically in Lgr5-positive stem cells.  
The aberrant reactivation of EMT in advanced cancer is believed to be a major 
contributor to tumour metastasis, which allows tumour cells to disseminate from 
primary tumours to distal sites (Thiery, 2002). As Runx3 is a negative regulator of 
EMT, its inactivation may render tumour cells prone to the pro-metastatic effects of 
EMT at later stages of gastric cancer. Indeed, preliminary studies have revealed that 
the loss of RUNX3 is significantly associated with poor clinical outcome in gastric 
cancer patients, and its reactivation leads to abrogation of metastasis in animal models 
(Wei et al., 2005).  Therefore, the protective role of Runx3 against gastric cancer 
metastasis could be further investigated. In conclusion, our findings implicate a 
safeguarding function of Runx3 against EMT-induced cellular plasticity and tumour-
initiation, and perhaps metastasis would partly explain the frequent inactivation of 
RUNX3 in human gastric cancers Thus, this reinforces that the reactivation of 
RUNX3 through the administration of DNA methylation inhibitors such as decitabine 
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